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Abstract 
This thesis consists of two scientific articles and is preceded by an overview that 
contextualises the published work.  
The first part of this thesis is comprised of Publication 1 and its corresponding 
supporting information. It is concerned with the synthesis of compounds of type 200 with 
various R substitutions utilising the Pd-catalysed Ullmann cross-coupling. Subjecting 
these compounds to a reductive cyclisation followed by aromatisation generates 
carbazoles 201 with various substitution patterns (Scheme 34). This methodology was 
also used to generate natural products 3-Methyl-9H-carbazole, Glycoborine, 
Glycozoline, Clauszoline K, Mukonine, and Karapinchamine A 
The second part of the thesis is comprised of Publication 2 and its corresponding 
supporting information that builds upon the above-mentioned publication, where we 
were able to generate compound 202. Subjecting this compound to a reductive 
cyclisation followed by aromatisation generates α-carboline 203 (Scheme 35). 
Compound 202 as its various N-regioisomers were also synthesised allowing access to 
β-, γ-, and δ-carbolines. This methodology was also used to generate natural product, 
β-carboline containing harman (204).  
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Scheme 34 Summary of Publication 1, a new synthetic approach to carbazoles. 
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Scheme 35 Summary of Publication 2, a new synthetic approach to carbolines. 
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1. Chapter One. Introduction: Ready Access to
Carbazole and Carboline Functionality Introduction 
1.1 Carbazoles 
9H-Carbazole (Figure 1, compound 1) was first isolated from the anthracene fraction of 
coal tar distillate in 1872 by Grabe and Glaser.1 In 1965, the first carbazole-containing 
natural product, murrayanine (Figure 1, compound 2) was isolated from the plant 
Murraya koenigii Spreng. (Fam. Rutaceae).2-3 The antimicrobial properties associated 
with murrayanine have generated great interest in the development of pathways to 
carbazole alkaloid synthesis. Since then, carbazole-containing compounds including 
natural products 3,4 45 and 5,6-7 have continued to inspire synthetic chemists. This is due 
to their intriguing structural features and manifold biological activities, which include 
antitumor, antibacterial, psychotropic, anti-inflammatory, antihistaminic, antimicrobial, 
anti-oxidative and antifungal properties, as well as antimalarial activity, further 
illustrating the medicinal relevance of carbazole chemistry. The carbazole moiety is 
therefore considered a pivotal pharmacophore for the development of new therapeutic 
agents. Examples of drugs that embody this motif include carvedilol (6)8 and carazolol 
(7),9 which are used to treat hypertension, ischemic heart disease and congestive heart 
failure. In addition to the vast array of biological activities, certain carbazoles also 
display properties likely to be of value in optoelectric materials, conducting polymers 
and synthetic dyes.  
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1.2 Biogenesis of the Carbazole Framework 
 
The biosynthesis of the carbazole framework is not well known, but the so-called 
“anthranilic acid pathway”, which proceeds via 3-prenylquinolone (17) to form the 
precursor compound 3-methylcarbazole (19), represents the most widely accepted 
proposal for the formation in higher plants (Scheme 1). This hypothesis is supported by 
the isolation of a range of carbazole alkaloids with a carbon centre formed from 3-
dehydroquinic acid (12), (carbon centre labelled in Scheme 1) by a sequence of 
dehydration and reduction steps that take place within the developing carbazole 
framework.10 
 
The biogenesis of the natural product 3-methylcarbazole as shown in Scheme 1, begins 
with shikimic acid (8).3 ATP-dependent phosphorylation of shikimic acid (8) gives 
shikimic acid 3-phosphate which combines with phosphoenolpyruvate (PEP) via an 
addition-elimination reaction giving 3-enolpyruvylshikimic acid 3-phosphate (EPSP). 
1,4-Elimination of phosphoric acid from EPSP leads to chorismic acid (9). Amination of 
chorismic acid (9) at C2 by L-glutamine (L-Gln) with elimination of water leads to 2-
amino-2-deoxyisochorismic acid (10) and then anthranilic acid (11) following 
aromatisation. Anthraniloyl-coenzyme A (CoA), obtained from anthranilic acid and 
acetyl-coenzyme A (CoA), effects a chain extension to give the quinolone 12 via the 
addition of one molecule of malonyl-CoA through amide formation. Quinolone 12, 
which later forms the indole unit of the carbazole framework, is then alkylated at the 
nucleophilic C3 position with prenyl pyrophosphate (16), affording 3-prenylquinoline 
(17). Prenyl pyrophosphate can be formed via two independent pathways depending on 
the organism: the mevalonate pathway in which prenyl pyrophosphate (16) is derived 
from mevalonic acid (13), or via the methylerythritol pathway (MEP) where prenyl 
pyrophosphate (16) is synthesised from 1-deoxy-D-xylulose (14) via methylerythritol 
phosphate (15). Mammals and fungi use the mevalonate pathway exclusively, while both 
can operate in plants, algae, and bacteria. The final step of the biosynthesis is thought to 
proceed via extrusion of carbon monoxide and subsequent oxidative cyclisation of the 
intermediate 2-prenylindole (18) to give 3-methylcarbazole (19).3 
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1.3. Established Methods for the Synthesis of Carbazoles 
 
Numerous routes to the tricyclic carbazole framework have been developed and 
representative approaches are outlined in the following section. 
 
Following conventional protocols, the three rings within the carbazole framework are 
labelled as A, B and C (Figure 1).  
 
Accordingly, the synthesis of carbazoles can be divided into three classes: 
 
1. The annulation of a benzenoid A or C ring to a substituted indole 
2. A modular construction made involving the stepwise (or simultaneous 
introduction) of each ring (A + B + C or some variation thereof) 
3. The construction of the central pyrrole (B) ring from a biphenyl derivative that 
therefore embodies the A and C rings.  
 
1.3.1 The Annulation of a Benzenoid A or C ring to a Substituted 
Indole 
 
The synthesis of carbazole from a substituted indole precursor can be classified as the 
annulation of either the A or C ring from an established indole core. Either the A or C 
ring can be synthesised from analogous precursors using similar chemistry, with 
differences only in the substitution pattern of the precursors (denoted by the R groups, 
Figure 2). For the purposes of the present discussion, the annulation of either the A or C 
ring to an indole core are considered equivalent.  
 
 20
N
H
A B C
N
H
B C
N
H
A B
211
+A +CR
1 R2R1R2
Figure 2 Synthesis of optionally "A or C" benzenoid rings from substituted indole 
derivatives 
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1.3.1.1 Electrocyclisation of Enamino Indole Precursors 
 
Mohanakrishnan and co-workers developed a route to functionalised carbazoles via 
electrocyclisation of an in situ-generated 2,3-dialkenylindole 24 (Scheme 2).11-13 Firstly, 
1-phenylsulfonyl-2-methyl-3-vinylindole (22) reacts with the cationic species 23, which 
is generated by extrusion of methanol from DMF·DMA (dimethyl formamide·dimethyl 
acetal) or DMA·DMA (dimethyl acetamide·dimethyl acetal) at 110 ºC, leading to the 
formation of compound 24. N-Protection is necessary for the electrocyclisation of 2,3-
dialkenylindole systems as the electron withdrawing phenylsulfonyl group on the indole 
nitrogen provides triene character to the 2,3-divinylindole system. The mechanism can be 
understood through the electrocyclisation of intermediate enamine 24 followed by 
aromatisation of the resulting dihydrocarbazole 25 via elimination of dimethylamine to 
give the observed carbazole 26. 
 
 
Scheme 2 Electrocyclisation of enamines to give carbazoles 
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1.3.1.2 Palladium-catalysed Electrocyclisation of Dialkenylindole 
Derivatives 
 
Langer et. al developed methods for the synthesis of carbazoles first involving a double-
barrelled Heck reaction followed by an electrocyclisation to build the tricyclic 1,2-
dihydrocarbazole motif.14-15 For example, 2,3-dibromo-N-methylindole (27) and 
acrylonitrile (28) react via a double Heck reaction to give triene intermediate 29 (Scheme 
3). A subsequent electrocyclic ring closure and oxidation gives the tricyclic 1,2-
dihydrocarbazole intermediate 30. Addition of another equivalent of acrylonitrile 28 in 
the presence of a base and subsequent aromatisation by elimination of hydrogen cyanide 
gives the carbazole 32. When HCN cannot be eliminated, these intermediates can be 
converted to the corresponding carbazoles following dehydrogenation with Pd/C (10 mol 
%) in xylenes. 
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Scheme 3 Synthesis of carbazole via successive two-fold Heck and 6π-electrocyclisation 
reactions 
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1.3.1.3 Palladium-catalysed Oxidative Cycloadditions of Indoles 
with Alkynes 
 
Miura, Satoh and co-workers reported the synthesis of 1,2,3,4-tetrasubstituted carbazoles 
(e.g. 41) through the palladium-catalysed oxidative coupling of N-substituted indoles 
and/or the corresponding carboxylic acid derivatives (34) with alkynes (37) using 
Pd(OAc)2 as the catalyst, Cu(OAc)2·3H2O as the stoichiometric oxidant and LiOAc as an 
additive (Scheme 4).16-17 The copper[II] salt oxidises the Pd[0] species to regenerate 
Pd(OAc)2. One possible role of added LiOAc is to provide acetate anions as ligands to 
prevent the deactivation of Pd[0] through formation of insoluble metal species.  
 
 
 
 
 
A possible mechanism for this conversion is shown in Scheme 5. Coordination of the 
carboxyl oxygen of compound 34 to Pd(OAc)2 with liberation of acetic acid gives a 
palladium(II) carboxylate 35, which undergoes directed palladation at the indole C2 
position to give the palladacycle 36.  Subsequent alkyne insertion and decarboxylation 
then gives compound 39. A second alkyne insertion followed by a reductive elimination 
affords the observed carbazole 40 and generates Pd[0], which is converted back to Pd[II] 
in the presence of Cu(OAc)2. 
Scheme 4 Pd-catalysed oxidative coupling of 1-methylindole-3-carboxylic acid with an 
alkyne 
N
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N
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Scheme 5 Possible mechanism for Pd-catalysed oxidative coupling of 1-methylindole-3-
carboxylic acid (34) with alkynes such as (37) 
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1.3.1.4 Platinum-catalysed Cyclisations of Indole-allenols 
 
Kong and co-workers developed a method to synthesise substituted carbazoles that 
involves the PtCl2-catalysed cyclisation of indol-2-yl-2,3-allenols such as 43 (Scheme 
6).18 The reaction of indole 41 and allene 42 gives indol-2-yl-2,3-allenol 43, which then 
undergoes cyclisation under PtCl2 catalysis to give the observed carbazole 48.  
 
 
 
 
 
 
 
 
 
 
A possible mechanism involving a metal carbenoid intermediate 47 is shown in Scheme 
7. Reaction of PtCl2 with indole 43 is presumed to begin with coordination of the allene 
moiety to the platinum catalyst. Nucleophilic attack of the indole C3 onto the metal-
activated electrophilic carbon double bond generates intermediate 45. Protonation of the 
hydroxyl group followed by elimination of H2O in intermediate 46 affords the cyclic 
platinum carbenoid 47. A 1,2-H shift of intermediate 47 gives the observed product 48, 
with concurrent regeneration of the catalyst PtCl2. 
 
 
 
Scheme 6 Pt(II)-catalysed cyclisation of 1-(indol-2-yl)-2,3-allenols from indoles to 
carbazoles 
N
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N
Et
• C5H11
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1.3.1.5 Ring-closing Metathesis 
 
Ring-closing metathesis (RCM) has become a widely adopted approach for carbon-
carbon bond formation, especially in the synthesis of cyclic compounds (Scheme 8). 
Bennasar et. al have exploited such an approach to carbazole 52.19-20 First, the indole-3-
carboxaldehyde 49 was treated with vinylmagnesium bromide 50 to generate diene 51, 
which then participates in a Grubbs I-catalysed RCM reaction. Dehydrative 
aromatisation of the primary product of this reaction gives carbazole 52.  
Scheme 7 Proposed mechanism for Pt(II)-catalysed cyclisation of 1-(indol-2-yl)-2,3-
allenols to carbazoles 
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1.3.2 A + B + C à ABC Routes to Carbazoles  
 
Carbazoles can also be prepared from monocyclic precursors through the sequential 
introduction of the remaining rings (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
1.3.2.1 Double Annulation via Palladium-catalysed Oxidative 
Cycloadditions with Alkynes 
 
The palladium-catalysed oxidative cycloaddition of alkynes with indoles reported by 
Miura, Satoh et al. as described in the previous section (Scheme 4), can be extended to a 
Scheme 8 Synthesis of carbazole using ring-closing metathesis 
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Figure 3 Formation of carbazoles in a modular-type sequence 
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double annulation approach (Scheme 9).16-17 Thus, stepwise couplings of 1-
methylpyrrole-2-carboxylic acid (56) with two different alkynes such as 57 and 59 
resulted in unsymmetrical and fully substituted carbazoles 60 via the formation of 
intermediate tetrasubstituted indole 58. The mechanism of this transformation is closely 
related to that outlined in Scheme 5. 
 
 
1.3.2.2 Carbazole Synthesis via Indole-2-carboxylate 
Intermediate 
 
Moody and co-workers synthesised murrayaquinone B (68) via an indole-2-carboxylate 
intermediate 64 (Scheme 10).21 The benzaldehyde 61 was treated with methyl 
azidoacetate 62 in the presence of sodium methoxide to give compound 63. This step was 
followed by thermally-induced cyclisation and Claisen rearrangement reactions to give 
compound 64. Subsequent methylation and condensation with 4-methylbutyrolacetone 
(65) resulted in the formation of compound 66. Heating in aqueous dioxane in the 
presence of NaOH facilitated lactone hydrolysis to the corresponding alcohol and 
concomitant decarboxylation. Pyridinium chlorochromate (PCC) oxidation to the 
Scheme 9 Synthesis of unsymmetrical and fully substituted carbazoles via [2+2+2] 
cycloaddition pathway 
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aldehyde followed by cyclization in the presence of BF3 afforded carbazole 67, which 
was readily converted to murrayaquinone B (68).  
 
 
 
1.3.2.3 Rhodium-catalysed Cycloadditions of Alkyne Derivatives: 
Vollhardt-type Cyclisation 
 
Witulski and co-workers utilised a sequence involving a Sonogashira cross-coupling, a 
chemo- and regioselective rhodium-catalysed cross alkyne cyclotrimerisation and 
palladium-catalysed arylamidation reactions as key steps in the first total synthesis of the 
carbazole-containing natural product antiostatin A1 (74) (Scheme 11).22-23   
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Scheme 10 Synthesis of murrayaquinone B via indole-2-carboxylate intermediate (64) 
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Specifically, the Sonogashira reaction of o-iodoaniline (69) with trimethylsilylacetylene 
followed by tosylation of the aniline nitrogen gave the anilide 70 that itself was 
converted into the diyne 71 in five steps. The critical [2+2+2] cyclotrimerisation reaction 
of diyne 71 with 1-methoxypropyne could be achieved using 10 mol % of Wilkinson’s 
catalyst [RhCl(PPh3)3] in toluene at room temperature to give the carbazole 73 as the 
major product as well as the regioisomer 72. The desired isomer 73 was converted to the 
natural product, antiostatin A1 (74) over four additional steps.  
 
 
 
Scheme 11 First total synthesis of antiostatin A1 by Rhodium-catalysed crossed [2+2+2] 
cycloadditions 
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1.3.3. The Formation of the Central Pyrrole (B) Ring from 
Biphenyl Derivatives.  
 
The final class of carbazole synthesis is the formation of the pyrrole ring (B) from 
biphenyl derivatives (Figure 4). This process can occur either by C–N bond formation 
from biphenyl derivative 75 or C–C bond formation with 76 to form the carbazole (1).  
 
 
 
 
 
 
 
1.3.3.1 Cadogan Cyclisation  
 
A common method for carbazole synthesis involves the reductive cyclisation of 2-
nitrobiphenyl derivatives in the presence of organophosphorus reagents, also known as 
the Cadogan cyclisation.24 Subjecting a range of 2-nitrobiphenyls to PPh3 in refluxing 
orthodichlorobenzene (o-DCB) gave the desired carbazoles in good yield. (Scheme 12)  
 
 
 
 
 
 
 
 
 
Scheme 13 shows the proposed mechanism for Cadogan cyclisation to carbazoles (85). 
Reductive deoxygenation via nucleophilic attack of PPh3 onto the nitro group gives 
compound (80), which is postulated to proceed via two alternate pathways to afford the 
carbazole. Path A involves first elimination of PPh3O followed by nitrene insertion and 
after elimination of H+, gives the desired carbazole (85). In path B, compound (80) 
Figure 4 Formation of pyrrole (B) ring from biphenyl derivatives 
 
Scheme 12 Cadogan cyclisation reaction to afford the carbazole framework   
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undergoes an initial cyclisation with elimination of PPh3O followed by H+ elimination, 
giving the desired carbazole (85).  
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Scheme 13 Proposed mechanism for Cadogan cyclisation to carbazoles 
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1.3.3.2 Hypervalent Iodine (III) Mediated Carbazole Synthesis 
 
Kajiyama and co-workers synthesised glycozoline (92) (Scheme 14) through an 
oxidative cyclisation using an electrochemically generated hypervalent iodine oxidant.25 
The Suzuki-Miyaura coupling of the boronic acid 87 with acetanilide 88 gave diaryl 89. 
The key oxidative cyclisation of compound 89 using oxidant PhI(OCH2CF3)2 (PIFA) 
proceeded under basic conditions via cyclisation of intermediate 90 to give the N-acetyl 
protected carbazole 91. Subsequent treatment with KOH/MeOH removed the acetyl 
group to give the target carbazole, glycozoline (92).  
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Scheme 14 Synthesis of glycozoline via hypervalent iodine (III) mediated 
oxidative cyclisation 
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1.3.3.3 Palladium(II)-catalysed Carbazole Synthesis 
 
Knölker and co-workers have extensively explored Pd-catalysed oxidative cyclisation of 
biarylamines to form the carbazole motif.26 The reaction sequence involves Pd[0]-
catalysed Buchwald-Hartwig amination of p-bromoanisole (93) and p-toluidine (94) and 
subsequent palladium[II]-catalysed oxidation cyclisation of the resulting product 95 to 
give 6-oxygenated carbazole alkaloids 96/97 as shown in Scheme 15. Deprotection of 
glycozoline (96) with boron tribromide gave glycozolinine (97). Glycozolinine (97) was 
further elaborated into other natural products through a series of manipulations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3.3.4. Iron-arene Complex-mediated Carbazole Synthesis 
 
Knölker also pioneered a new route to carbazoles involving an arylation mediated by an 
iron-arene complex followed by intramolecular C–N bond formation.27-28 The group 
reported the synthesis of (–)-neocarazostatin B (103) and carquinostatin A (104) via this 
iron-mediated oxidative cyclisation (Scheme 16).29  
 
The reaction of the tetrafluoroborate salt of the iron-arene complex 98 and aryl amine 99 
gave the tricarbonyliron–coordinated carbazole 100 in a single step. Aromatisation and 
Scheme 15 Oxidative cyclisation of biarylamines to carbazoles; synthesis of 
glycozolinine and glycozoline 
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demetallation with NBS under basic conditions afforded the bromocarbazole 101. 
Treatment of compound 101 with prenyl bromide and Ni(CO)4 in benzene gave 
compound 102. Removal of the acetate protecting groups with LiAlH4 afforded (–)-
neocarazostatin B (103), which could be converted into carquinostatin A (104) under 
oxidative conditions (ceric(IV) ammonium nitrate). 
 
 
1.3.3.5 Graebe-Ullmann Synthesis 
 
The Graebe-Ullmann synthesis is the transformation of 1-phenylbenzotriazole (106) to a 
carbazole (1) under thermal reaction conditions.30 The benzotriazole can be prepared by 
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Scheme 16 Synthesis of (–)-neocarazostatin B and carquinostatin A via iron-arene mediated 
synthesis 
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diazotisation of N-(2-aminophenyl)aniline (105) and under thermal conditions gives the 
resulting carbazole (1) (Scheme 17). Little is known about the reaction mechanism but 
this transformation is thought to proceed via a diradical intermediate generated in the 
thermolysis of the triazole. 
 
 
 
 
 
 
 
1.3.3.6 Fischer Indolisation 
 
A common method of preparing carbazoles utilises the Fischer indole synthesis of 
1,2,3,4-tetrahydrocarbazole and subsequent aromatisation. The Fischer indolisation (or 
Fischer-Borsche synthesis, Borsche-Dreschel reaction) is a classical illustration of indole 
synthesis and a common method of synthesising carbazoles.31-32 Fischer indolisation of 
Cbz-protected aryl hydrazines 107 with cyclohexanone (108) in acidic conditions gives 
the annulated indole/1,2,3,4-tetrahydrocarbazole 109 (Scheme 18).33 Following 
condensation of the hydrazine and ketone to afford an ene-hydrazine, this reaction 
involves protonation, formation of a new C-C bond via a [3,3]-sigmatropic 
rearrangement and elimination of ammonia. Borsche was the first to realise the scope of 
the Fischer indole synthesis and demonstrate its use to prepare a wide range of 
tetrahydrocarbazoles.34 Both organic and inorganic acids such as sulfuric and acetic acid 
have been employed, although acetic acid provided products in superior purities. 
Oxidative aromatisation of 1,2,3,4-tetrahydrocarbazole 109 with an oxidant such as DDQ 
in benzene gave the corresponding carbazole 110. Other oxidants such as lead oxide, 
mercury acetate, palladium chloride, chloranil or Pd/C have also been employed. 
Scheme 17 Graebe-Ullmann synthesis of carbazoles 
N
H
N
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1.3.3.7 Bucherer Carbazole Synthesis 
 
The Bucherer carbazole synthesis is the reaction of a-naphthols 111 (or a-
naphthylamines) with phenylhydrazine (113) and leads to the formation of 3,4-
benzocarbazoles (118) (Scheme 19).35  
 
The reaction of 3-tetralone-1-sulfonate (112) with phenylhydrazine (113) as a 
nucleophile in 40 % acetic acid at room temperature afforded the phenylhydrazinium 1,2-
dihydro-3,4-benzocarbazole-2-sulfonate (117) via a series of protonation steps. 
Subsequent loss of ammonia and NaHSO3 gave the desired 3,4-benzocarbazole (118). 
 
Scheme 18 Fischer indole route to carbazoles 
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In principle, the Bucherer carbazole synthesis, the Fischer indole synthesis and Borsche-
Drechsel carbazole synthesis from phenylhydrazines and cyclic ketones all proceed in a 
similar fashion. 
H2NHN
AcOH
OH O
NaO3S
HN
NaO3S
NH
H2N
NaO3S
NH
H
NH2
NaO3S
NHH2N
NaO3S
N
H
H
-NH3, -NaHSO3
N
H
111 112 113 114
115116117
118
H
Scheme 19 Bucherer carbazole synthesis to 3,4-benzocarbazoles 
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1.4 Carbolines (a-, b-, g-, d-) 
 
Pyrido[b]indoles are known as carbolines. Carbolines consist of a tricyclic moiety 
structurally related to both indole and carbazole compounds and depending on the way in 
which the rings are fused, they are designated as a-, b-, g-, d-, respectively (Figure 5).36 
 
 
 
The a-carboline structure (pyrido[2,3-b]indole) (119) forms the core structure of a 
number of natural products.37 While not as common in nature as β-, γ- carbolines, interest 
in the synthesis of natural and synthetic a-carbolines has arisen due to their cytotoxicity, 
anticancer and CNS activity.36 
 
β-Carboline alkaloids (120) are widespread in plants and animals, and frequently act as 
benzodiazepine inverse agonists. As components of the liana Banisteriopsis caapi, the β-
carbolines harmine, harmaline, and tetrahydroharmine play a pivotal role in the 
pharmacology of the indigenous psychedelic drug ayahuasca.38 These compounds 
prevent the breakdown of dimethyltryptamine in the gut by reversibly inhibiting 
monoamine oxidase, thus making them psychoactive upon oral administration. Some β-
carbolines, notably tryptoline and pinoline, may be formed naturally in the human body. 
The importance of β-carbolines demands efficient synthetic methodologies.  
 
g-Carbolines (121) are less studied than their β-carboline analogues 120, however, the 
biological properties of g-carboline (121) are equally important as their β-counterparts 
(120). Compounds containing g-carbolines (121) have attracted interest due to their 
ability to inhibit the activity of monoamine oxidase (MAO) and to influence the effects 
of important neurotransmitters such as histamine and serotonin.39  
119
NN
H
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N
N
H
121
N
N
H
122
N
N
H
γ-carbolineα-carboline β-carboline δ-carboline
Figure 5 Isomers of Carbolines 
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The carboline core is usually built from a suitable functionalised indole such as a 
tryptamine derivative, onto which the fused pyridine ring is introduced. Indoles, which 
are activated substrates, efficiently undergo intramolecular Friedel-Crafts-type reactions 
such as Pictet-Spengler (PS) and the Bischler-Napieralski (BN) reactions. Methodologies 
based on transition metal catalysed cyclisation for the synthesis of the pyrrole ring have 
also emerged in recent times.40 Subsequent functionalisation en route to natural products 
or synthetic drug candidates may be necessary. 
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1.5 Key reactions utilised in this Thesis 
 
1.5.1 The Ullmann Reaction 
 
The Ullmann reaction is a classic C–C bond forming process.41 The original form of this 
reaction was reported in 1901 and involved the homo-coupling of two equivalents of an 
aryl halide 123 in the presence of copper powder at high temperature to give the 
corresponding symmetrical biaryl 124 (Scheme 20).42  
 
 
 
Since the discovery of the Ullmann reaction, its general scope and limitations have been 
established. These are summarised below and in Scheme 21.41 Evano, Blanchard and 
Toumi provide an in-depth review of the topic.41 
 
• Both halogenated aromatic and heteroaromatic compounds can participate in the 
reaction; 
• Aryl iodides are more reactive than their bromide counterparts, which are more 
reactive than the corresponding aryl chlorides. 
• Substituents can affect the reactivity. Electron-withdrawing groups (especially 
NO2, –COOR, –CHO) located in the ortho-position relative to the halogen can 
facilitate the coupling process. Conversely, bulky groups can have a detrimental 
effect, while electron-donating groups anywhere on either ring generally diminish 
the yields and decrease the rate of cross-coupling. 
• Copper powder with freshly cleaned metal surfaces is normally used.  
• DMF is the most common solvent used, although pyridine, quinolone, 
nitrobenzene, DMSO and p–nitrotoluene have also been employed.  
• Long reaction times and temperatures in excess of 200 °C are often required to 
achieve reasonable reaction rates. 
Cu
210-220 °C
NO2
O2N
2 CuBr2
NO2
Br
neat
123 124
Scheme 20 Original Ullmann Reaction 
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• In cross-coupling reactions, the corresponding homo-coupling products are 
commonly encountered by-products. 
• Further developments of the Ullmann reaction extend beyond C–C bond 
formation to the synthesis of diarylamines, diarylethers and arylamides. Examples 
of this are shown in Scheme 21. Carbon–heteroatom bond formations can often 
be competing reactions if the substrate contains acidic hydrogens (–OH, –COOH, 
–NH2, –SO2NH2).  
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Scheme 21 Variations of Ullmann reaction: Synthesis of diarylamines, diarylethers and 
arylamides 
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1.5.2 The Palladium[0]-catalysed Ullmann Cross-coupling 
Reaction 
 
The Pd[0]-catalysed variant of the Ullmann cross-coupling reaction was first reported in 
1993 by Shimizu and co-workers and used aryl bromide 123, iodopyridine 135, four 
equivalents of copper powder and 5 mol % of Pd(PPh3)4 as a catalyst to form (2-
nitrophenyl)pyridine 136 (Scheme 22).43  
 
 
Shimizu and co-workers reported a wide range of Pd catalysts including Pd(PPh3)4, 
PdCl2, and PdCl2(PPh3)2. The most notable outcome from the study was that the cross-
coupling reactions could be conducted under relatively mild conditions and homo-
coupling was not observed. 
 
1.5.3 The Pd[0]-catalysed Ullmann Cross-coupling Route to 
Indoles 
 
The Pd[0]-catalysed Ullmann cross-coupling has provided a useful route to indoles. 
Typically, this important heterocyclic ring system is obtained by using the Fischer indole 
synthesis as described previously. The limitations of this approach include the harsh 
conditions required to perform the [3,3]–sigmatropic rearrangement of the intermediate 
ene-hydrazine and lack of regiocontrol when using ketones with more than one 
enolisable proton. However, Scott and Soderberg (Scheme 23) have reported the use of a 
Stille coupling with aryl tin compound 137 and cyclic enone 138 to produce compound 
139, a precursor to carbazoles.44 This process allows for complete regiocontrol in the 
formation of the C–C bond which has provided important background to the work in this 
thesis.  
N NO2N
I Br
NO2
Cu, Pd(PPh3)4
DMSO, 130 ºC
1 h
90%
135 136123
Scheme 22 First example of a Pd[0]-catalysed Ullmann cross-coupling reaction 
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A recent Pd[0]-catalysed Ullmann cross-coupling approach by Banwell and co-workers 
addresses the regiochemical issues associated with the Fischer indole synthesis while 
also avoiding the use of stannanes.45 The method involves a simple two-step protocol 
from readily available starting materials and reagents. As with other Ullmann cross-
coupling methods, the reaction is performed directly between two halogenated substrates; 
Suzuki, Negishi, Stille and Kumada protocols differ as they typically involve cross-
coupling between a preformed metallated species. 
 
Banwell and coworkers’ two-step protocol to annulated indoles, shown in Scheme 24, 
proceeds first with a Pd[0]-catalysed Ullmann cross-coupling reaction, followed by a 
reductive cyclisation to form tetrahydrocarbazole 143.45 
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Scheme 23 Scott and Soderberg Stille Coupling of tributyl(2-nitrophenyl)stannane and 
a-halocyclohexenone 
Scheme 24 Pd[0]-catalysed Ullmann Cross-coupling reaction to Indoles 
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Based on a postulated catalytic cycle by Shimizu, Scheme 25 depicts the proposed 
mechanism of the Pd[0]–catalysed Ullmann cross-coupling reaction. It is presumed that 
the aryl halide 146 is selectively metallated with copper[0] to give the copper derivative 
147 while the cyclic enone 144 undergoes oxidative addition with palladium[0] to give 
the palladium intermediate 145. Transmetallation affords the palladium[II] species 148, 
which undergoes a reductive elimination to give the desired cross-coupled product 149.  
 
 
The Pd[0]-catalysed Ullmann cross-coupling product was subjected to reaction with 
hydrogen in the presence of palladium on carbon to generate the target indole.  It is 
speculated that indole formation can occur through one of two pathways or a 
combination of the two. One pathway (Scheme 26, Path A) involves initial reduction of 
the enone double bond of compound 150 to give compound 151. The resulting 
intermediate 151 then undergoes reduction of the nitro moiety to give the aniline 152 
which engages in an intramolecular Schiff base condensation reaction. This is followed 
PdL2
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2 Cu
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I
O
I
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O
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R
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O
O
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Scheme 25 Catalytic cycle proposed for the Pd[0]-catalysed cross-coupling of a-
iodocyclohexenone and 2-iodonitrobenzene derivatives 
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by tautomerisation of the initially formed isoindole to give its aromatic counterpart 155. 
The second pathway (Scheme 26, Path B) begins with the reduction of the aromatic nitro 
moiety of compound 150 to the corresponding aniline 153. The latter can then undergo 
an intramolecular Schiff base condensation reaction to give isoindole 164. At this point 
the carbon–carbon double bond is reduced and, following tautomerisation, the annulated 
indole 155 is formed. There is literature evidence to support path A, where a compound 
was isolated where reduction of the double bond has occurred but the nitro moiety was 
left untouched.  
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Scheme 26 Possible pathways associated with the reductive cyclisation of the cross-
coupling product 150 to give annulated indole 155.  
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1.5 Key reactions utilised in this Thesis 
  
1.5.1 The Ullmann Reaction 
 
The Ullmann reaction is a classic C–C bond forming process.41 The original form of this 
reaction was reported in 1901 and involved the homo-coupling of two equivalents of an 
aryl halide 123 in the presence of copper powder at high temperature to give the 
corresponding symmetrical biaryl 124 (Scheme 20).42  
 
 
 
Since the discovery of the Ullmann reaction, its general scope and limitations have been 
established. These are summarised below and in Scheme 21.41 Evano, Blanchard and 
Toumi provide an in-depth review of the topic.41 
 
• Both halogenated aromatic and heteroaromatic compounds can participate in the 
reaction; 
• Aryl iodides are more reactive than their bromide counterparts, which are more 
reactive than the corresponding aryl chlorides. 
• Substituents can affect the reactivity. Electron-withdrawing groups (especially 
NO2, –COOR, –CHO) located in the ortho-position relative to the halogen can 
facilitate the coupling process. Conversely, bulky groups can have a detrimental 
effect, while electron-donating groups anywhere on either ring generally diminish 
the yields and decrease the rate of cross-coupling. 
• Copper powder with freshly cleaned metal surfaces is normally used.  
• DMF is the most common solvent used, although pyridine, quinolone, 
nitrobenzene, DMSO and p–nitrotoluene have also been employed.  
• Long reaction times and temperatures in excess of 200 °C are often required to 
achieve reasonable reaction rates. 
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Scheme 27 Original Ullmann Reaction 
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• In cross-coupling reactions, the corresponding homo-coupling products are 
commonly encountered by-products. 
• Further developments of the Ullmann reaction extend beyond C–C bond 
formation to the synthesis of diarylamines, diarylethers and arylamides. Examples 
of this are shown in Scheme 21. Carbon–heteroatom bond formations can often 
be competing reactions if the substrate contains acidic hydrogens (–OH, –COOH, 
–NH2, –SO2NH2).  
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Scheme 28 Variations of Ullmann reaction: Synthesis of diarylamines, diarylethers and 
arylamides 
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1.5.2 The Palladium[0]-catalysed Ullmann Cross-coupling 
Reaction 
 
The Pd[0]-catalysed variant of the Ullmann cross-coupling reaction was first reported in 
1993 by Shimizu and co-workers and used aryl bromide 123, iodopyridine 135, four 
equivalents of copper powder and 5 mol % of Pd(PPh3)4 as a catalyst to form (2-
nitrophenyl)pyridine 136 (Scheme 22).43  
 
 
Shimizu and co-workers reported a wide range of Pd catalysts including Pd(PPh3)4, 
PdCl2, and PdCl2(PPh3)2. The most notable outcome from the study was that the cross-
coupling reactions could be conducted under relatively mild conditions and homo-
coupling was not observed. 
 
1.5.3 The Pd[0]-catalysed Ullmann Cross-coupling Route to 
Indoles 
 
The Pd[0]-catalysed Ullmann cross-coupling has provided a useful route to indoles. 
Typically, this important heterocyclic ring system is obtained by using the Fischer indole 
synthesis as described previously. The limitations of this approach include the harsh 
conditions required to perform the [3,3]–sigmatropic rearrangement of the intermediate 
ene-hydrazine and lack of regiocontrol when using ketones with more than one 
enolisable proton. However, Scott and Soderberg (Scheme 23) have reported the use of a 
Stille coupling with aryl tin compound 137 and cyclic enone 138 to produce compound 
139, a precursor to carbazoles.44 This process allows for complete regiocontrol in the 
formation of the C–C bond which has provided important background to the work in this 
thesis.  
N NO2N
I Br
NO2
Cu, Pd(PPh3)4
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135 136123
Scheme 29 First example of a Pd[0]-catalysed Ullmann cross-coupling reaction 
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A recent Pd[0]-catalysed Ullmann cross-coupling approach by Banwell and co-workers 
addresses the regiochemical issues associated with the Fischer indole synthesis while 
also avoiding the use of stannanes.45 The method involves a simple two-step protocol 
from readily available starting materials and reagents. As with other Ullmann cross-
coupling methods, the reaction is performed directly between two halogenated substrates; 
Suzuki, Negishi, Stille and Kumada protocols differ as they typically involve cross-
coupling between a preformed metallated species. 
 
Banwell and coworkers’ two-step protocol to annulated indoles, shown in Scheme 24, 
proceeds first with a Pd[0]-catalysed Ullmann cross-coupling reaction, followed by a 
reductive cyclisation to form tetrahydrocarbazole 143.45 
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Based on a postulated catalytic cycle by Shimizu, Scheme 25 depicts the proposed 
mechanism of the Pd[0]–catalysed Ullmann cross-coupling reaction. It is presumed that 
the aryl halide 146 is selectively metallated with copper[0] to give the copper derivative 
147 while the cyclic enone 144 undergoes oxidative addition with palladium[0] to give 
the palladium intermediate 145. Transmetallation affords the palladium[II] species 148, 
which undergoes a reductive elimination to give the desired cross-coupled product 149.  
 
 
The Pd[0]-catalysed Ullmann cross-coupling product was subjected to reaction with 
hydrogen in the presence of palladium on carbon to generate the target indole.  It is 
speculated that indole formation can occur through one of two pathways or a 
combination of the two. One pathway (Scheme 26, Path A) involves initial reduction of 
the enone double bond of compound 150 to give compound 151. The resulting 
intermediate 151 then undergoes reduction of the nitro moiety to give the aniline 152 
which engages in an intramolecular Schiff base condensation reaction. This is followed 
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Scheme 32 Catalytic cycle proposed for the Pd[0]-catalysed cross-coupling of a-
iodocyclohexenone and 2-iodonitrobenzene derivatives 
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by tautomerisation of the initially formed isoindole to give its aromatic counterpart 155. 
The second pathway (Scheme 26, Path B) begins with the reduction of the aromatic nitro 
moiety of compound 150 to the corresponding aniline 153. The latter can then undergo 
an intramolecular Schiff base condensation reaction to give isoindole 164. At this point 
the carbon–carbon double bond is reduced and, following tautomerisation, the annulated 
indole 155 is formed. There is literature evidence to support path A, where a compound 
was isolated where reduction of the double bond has occurred but the nitro moiety was 
left untouched.  
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1.6 Prior contributions to Pd[0]-catalysed Ullmann Cross-
coupling Reaction and Reductive Cyclisation: Indole and Natural 
Product synthesis 
 
The Banwell group has used the Pd[0]-catalysed Ullmann cross-coupling protocol 
extensively.45 Systematic trials indicated that a variety of palladium catalysts could be 
utilised; the combination of Pd2(dba)3, Cu[0] powder, iodinated versions of both coupling 
partners and DMSO as the solvent proved most effective. These conditions allowed the 
Ullmann cross-coupling reaction to proceed at temperatures around 50-70 °C (compared 
to prior approaches which proceeded at 200 °C).  Minimal homo-coupling was observed 
under these conditions. A library of indoles, varying in the sizes of the appended ring 
structures, was generated in the two-step protocol in good yields (Scheme 27).45 
 
 
 
The Banwell group has successfully exploited the Pd[0]-catalysed Ullmann cross-
coupling reaction in the synthesis of several natural products and details of each of these 
are presented in the following section. 
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Scheme 34 Indole formation by Pd[0]-catalysed Ullmann cross-coupling and reductive 
cyclisation.  
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1.6.1 Synthesis of (±)-apsidospermidine 
 
The synthesis of the apsidosperma alkaloid (±)-apsidospermidine (Scheme 28, 
compound 171) utilises the Pd[0]-catalysed Ullmann cross-coupling as one of the key 
steps.46-47 The a-iodocylohexenone 165 was prepared in 11 steps from commercially 
available 3-ethoxycyclohexenone in a protocol described by Banwell and Lupton. 
Together with commercially available o-iodonitrobenzene 140, the a-iodocyclohexenone 
165 was subjected to a Pd[0]-catalysed Ullmann cross-coupling. This involved five 
equivalents of copper powder, catalytic Pd2(dba)3, and DMSO as the solvent at 70 °C. 
The cross-coupled product 166, was hydrolysed to the alcohol, converted to the mesylate 
and reacted with sodium azide in DMF to give compound 167. The resulting azide 167 
engaged in a 1,3-dipolar cycloaddition after heating in benzene for three days to form, 
via an intermediate triazoline, aziridine 168. The regioselective cleavage of the aziridine 
168 was achieved by treatment with HCl in CH2Cl2 and the resulting hydrochloride salt 
of the a-chloroketone 169 was immediately subjected to reduction using ten molar 
equivalents of TiCl3×3THF in the presence of ammonium acetate which afforded indole 
170. Compound 170 was transformed to the target molecule (±)-apsidospermidine 171 in 
a further three steps.46-47 
  40 
 
 
 
 
1.6.2 Synthesis of (±)-limaspermidine 
 
The Pd[0]-catalysed Ullmann cross-coupling reaction was also a crucial step in the 
synthesis of the apsidosperma alkaloid (±)-limaspermidine (Scheme 29, 175).48 In four 
steps, the relevant a-iodocyclohexenone 171 was prepared and coupled with 
commercially available o-iodonitrobenzene (140) using five equivalents of copper 
powder, catalytic Pd2(dba)3 and DMSO as the solvent at 70 °C for 0.5 h. The resulting 
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Scheme 35 Banwell and Lupton’s synthesis of (±)-apsidospermidine 
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compound 173 was subjected to a pivotal reductive cyclisation using a large excess of 
Raney-cobalt in methanol and five molar equivalents of p-TsOH, which resulted in the 
exclusive formation of the cis-ring fused product 174. A further four steps afforded the 
natural product (±)-limaspermidine (175). 
 
 
 
1.6.3 Synthesis of the ABCD-ring substructure of strychnine  
 
Work by Reekie and Banwell towards the synthesis of strychnine used the key Pd[0]-
catalysed Ullmann cross-coupling and a Raney cobalt-mediated tandem reductive 
cyclisation to construct the ABCD-ring substructure of strychnine (Scheme 30, 181).49 
The commercially available cyclohexenone 186 was converted in four steps to the 
desired cyclic enone 177 and subsequently subjected to Pd[0]-catalysed Ullmann cross-
coupling conditions with o-iodoonitrobenzene (140) to afford the a-arylcyclohexenone 
178. Refluxing a solution of compound 178, Raney-cobalt and p-toluenesulfonic acid 
monohydrate (p-TsOH×H2O) under an atmosphere of hydrogen gave the desired 
tetracyclic ABCD-ring system of the Strychnos alkaloid family, compound 179. The E 
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Scheme 36 Banwell and Tan's synthesis of (±)-limaspermidine 
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ring can be constructed in an additional 4 steps to give the western hemisphere of 
strychnine, compound 180.  
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Scheme 37 Reekie and Banwell's synthesis of the ABCD-ring substructure of strychnine 
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1.7 Recent literature on Pd[0]-catalysed Ullmann Cross-coupling 
Reactions 
 
In 2007, Nicolaou and co-workers synthesised kinamycins C (186), F (187) and J (188) 
using the Pd[0]-catalysed Ullmann cross-coupling protocol developed by the Banwell 
group as a key step (Scheme 31).50 The required bromo-aldehyde B 182 was prepared in 
five steps and the enantiomerically pure iodoenone coupling partner 183 was prepared in 
six steps. Both starting materials were prepared on a multigram scale and subjected to 
Ullmann conditions to give the cross-coupled product 184 in 83% yield. A further 11 
steps gave the key intermediate 185, which after exposure to aq. HCl in acetonitrile 
provided kinamycin C (186). LiOH-mediated removal of all protecting groups of the 
intermed
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Scheme 38 Kinamycin synthesis via Pd[0]-catalysed Ullmann cross-coupling reaction 
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iate 185 gave kinamycin F 187. Acetylation of compound 185, followed by TBS-ether 
cleavage (aq. HCl, acetonitrile) furnished kinamycin J (188).   
 
Han and co-workers51 applied this strategy to the cross-coupling of 3-iodochromones, 
thiochromones and quinolones with ethyl bromodifluoroacetate (Scheme 32) to provide 
a succinct method for the construction of 3-ethoxycarbonyldifluoromethyl chromones, 
thiochromones, and quinonolones. Optimum conditions were developed using 5% 
Pd(dppf)Cl2, two equivalents of BrCF2COOEt, four equivalents of copper powder and 
DMSO at 60 °C. This reaction is compatible with a variety of functional groups 
including electron-donating methyl, methoxy, and aryl groups as well as electron-
withdrawing fluorinated and chlorinated substituents.  
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Scheme 39 Aryl difluoroacetates prepared via the Pd[0]-catalysed Ullmann 
cross-coupling of 189 and BrCF2COOEt 
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1.8 Our Proposed Approach to Carbazoles 
 
Given the robust nature of the Pd[0]-Ullmann cross-coupling protocol, we proposed that 
it could be used as a key step for in the synthesis of carbazoles, We proposed first 
involve the Pd[0]-catalysed Ullmann cross-coupling reaction between an a-halogentated, 
a,b-unsaturated cyclic enone 140 and an o-haloarene 144 to afford compound 142. 
Through careful choice of reduction conditions, based on research conducted through the 
group as outlined in prior chapters, the nitro moiety could be reduced while preserving 
the double bond from the cyclic enone, thus providing amine 197. After intramolecular 
Schiff base formation, it was envisaged that a spontaneous oxidation could occur to give 
the desired carbazole (1), (Scheme 33).  
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Scheme 40 Our proposed carbazole synthesis via a Pd[0]-catalysed Ullmann cross-coupling 
reaction. 
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1.9 Thesis Overview 
 
This thesis details two publications that examines the proposed approach to carbazole 
synthesis. Publication 1 examines the Ullmann cross coupling for the synthesis of 
carbazole derivatives. Publication 2 builds upon this work to generate a range of 
carbolines. 
 
Publication 1: A Palladium-Catalyzed Ullmann Cross-Coupling/Reductive 
Cyclization Route to the Carbazole Natural Products 3-Methyl-9H-carbazole, 
Glycoborine, Glycozoline, Clauszoline K, Mukonine, and Karapinchamine A. 
The first publication arising from this thesis explores the synthesis of compounds of type 
200 with various R substitutions utilising the Pd-catalysed Ullmann cross-coupling. 
Subjecting these compounds to a reductive cyclisation followed by aromatisation 
generates carbazoles 201 with various substitution patterns (Scheme 34). This 
methodology was also used to generate natural products 3-Methyl-9H-carbazole, 
Glycoborine, Glycozoline, Clauszoline K, Mukonine, and Karapinchamine A. 
 
 
Publication 2: A Unified Approach to the Isomeric α-, β-, γ-, and δ-Carbolines via 
their 6,7,8,9-Tetrahydro Counterparts 
In the second publication arising from this thesis, building upon the above mentioned 
publication, we were able to generate compound 202. Subjecting thise compounds to a 
reductive cyclisation followed by aromatisation generates α-carboline 203 (Scheme 35). 
Compound 202 as its various N-regioisomers were also synthesised allowing access to 
β-, γ-, and δ-carbolines. This methodology was also used to generate natural product, 
β-carboline containing harman (204).  
O
NO2
(i) reductive cyclisation
(ii) aromatisation NH
201
R
R
RR
200
Scheme 34 Summary of Publication 1, a new synthetic approach to carbazoles. 
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ABSTRACT: The title natural products 2−7 have been prepared by
reductive cyclization of the relevant 2-arylcyclohex-2-en-1-one (e.g.
20) to the corresponding tetrahydrocarbazole and dehydrogenation
(aromatization) of this to give the target carbazole (e.g. 4).
Compounds such as 20 were prepared using a palladium-catalyzed
Ullmann cross-coupling reaction between the appropriate 2-
iodocyclohex-2-en-1-one and o-halonitrobenzene.
■ INTRODUCTION
9H-Carbazole (1) (Figure 1) was ﬁrst isolated from coal tar
more than 100 years ago,1 and since that time this aromatic
heterocycle and its various derivatives have fascinated organic
chemists because of their value in both medicine and materials
science.2 Many biologically active natural products embodying
this framework have also been isolated, particularly from higher
plants.2d,e,3 As such, the development of methods for the
synthesis of the carbazoles has been an ongoing ﬁeld of
research. A suite of approaches to these compounds has been
reported, ranging from the classical Fischer−Borsche4 and
Graebe−Ullmann5 routes to more contemporary ones such as
the cyclization of biarylnitrenes (Cadogan synthesis)6 or
variants thereof and the annulation of indoles,7 including
through electrocyclization processes. Despite the demonstrated
utility of these and other approaches,8 perhaps the most
eﬀective route to carbazoles involves the cyclization of
diarylamines, especially under oxidative conditions.9 Variations
on this last approach have been used to great eﬀect in
developing total syntheses of a plethora of carbazole-containing
natural products, with particularly notable contributions having
being made, especially in recent times, by the Knölker
group.2,9e−i,k,m
Sometime ago we reported10 that 1,2,3,4-tetrahydro-9H-
carbazoles (formally 2,3,4,9-tetrahydro-1H-carbazoles) can be
formed by a two-step process involving an initial the palladium-
catalyzed Ullmann cross-coupling of 2-halocyclohex-2-en-1-
ones with o-halonitrobenzenes and then subjecting the resulting
2-arylcyclohex-2-en-1-ones to a reductive cyclization reaction.11
Since various methods are available for or could be applied to
the oxidation of tetrahydrocarbazoles to carbazoles,12 we
sought to establish if the reaction sequence just mentioned
could provide a useful means for obtaining natural products
embodying the latter ring system. Herein we report the
outcomes of such studies and by which means we have been
able to realize syntheses of the parent carbazole (1) as well as
the natural products 3-methyl-9H-carbazole (2),13 glycoborine
(3, aka glycrophylamine),3a,14 glycozoline (4),3a,15 clauszoline K
(5),16 mukonine (6),17 and karapinchamine A (7)18 together
with their monomethoxylated congener 8 (Figure 2).
■ RESULTS AND DISCUSSION
Our initial studies focused on acquiring targets 1 and 2, and this
involved (Scheme 1) the initial palladium-catalyzed Ullmann
cross-coupling of 2-iodocyclohex-2-en-1-one (9)19 or its C4-
methylated counterpart 1011 with commercially available o-
bromonitrobenzene (11) under conditions deﬁned earlier,10
and thereby aﬀording the anticipated and previously reported
2-arylcyclohex-2-en-1-ones 1210,11 (85%) and 1311 (86%),
respectively. A methanolic solution of each of compounds 12
and 13 was then subjected to reaction with hydrogen in the
presence of commercially available W-2 Raney nickel at room
temperature, and so aﬀording the tetrahydrocarbazoles
1410,11,12b (64%) and 1511,12b (58%), respectively. Various
Received: January 8, 2017
Published: February 22, 2017
Figure 1. Structure of parent 9H-carbazole (1) and the associated ring
labeling and atom numbering.
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attempts to modify these reductive cyclization conditions in an
eﬀort to obtain dihydrocarbazoles (or perhaps even the
carbazoles themselves as a result of conducting the workup
under aerobic conditions) were unsuccessful. In the ﬁnal step of
the reaction sequence, then, mesitylene solutions of com-
pounds 14 and 15 were each heated to 150 °C with an equal
weight of 10% palladium on carbon, and thus aﬀording
carbazoles 1 (55%) and 212b (57%), respectively. All of the
spectroscopic and physical data acquired on these reaction
products were in complete accord with the assigned structures
and matched those derived from a commercially available
sample (in the former case) or reported6h,12b in the literature
(in the latter case). Furthermore, each was subjected to single-
crystal X-ray analysis.20
The preparation of glycoborine (3), a synthetic target
pursued by others,6e,g,k,9h,k,14 was readily accomplished as
shown in Scheme 2 by coupling 2-iodo-4-methylcyclohex-2-en-
1-one (10)11 with nitroarene 1621 and thereby producing the
arylated cyclohexenone 17 (88%), the structure of which was
secured by a single-crystal X-ray analysis.20 The appearance of
28 signals in the 13C NMR spectrum of this C14 compound
suggested that it existed as diastereoisomeric atropisomers
under ambient conditions. Reductive cyclization of compound
17 using hydrogen in the presence of W-2 Raney nickel gave
the tetrahydrocarbazole 1811a (72%), and dehydrogenation of
this compound under the same conditions as employed before
then aﬀorded the target natural product 3, that was obtained in
75% yield. Once again, all of the appropriate spectral
comparisons left no doubt that the glycoborine had been
obtained but ﬁnal conﬁrmation of this followed from a single-
crystal X-ray analysis.20
A reaction sequence essentially analogous to that described
above was used to synthesize glycozoline (4), a compound that
has also been the target of previous studies.3c,4c,6i,12b,22 Thus, as
shown in Scheme 3, reaction of 2-iodo-4-methylcyclohex-2-en-
1-one (10) with commercially available nitroarene 19 under the
by now standard palladium-catalyzed Ullmann cross-coupling
conditions gave the anticipated product 20 (87%), which was
reductively cyclized with hydrogen in the presence of W-2
Figure 2. Structures of natural products 2-7 and the monosubstituted congener 8.
Scheme 1. Reaction Sequences Leading to Carbazoles 1 and
2
Scheme 2. Synthesis of Glycoborine (3)
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Raney nickel and so providing the tetrahydrocarbazole
2112b,d,22b in 72% yield. Dehydrogenation of compound 21
through brief treatment with 10% Pd on C in diphenyl ether at
210 °C then gave glycozoline (4) in 89% yield, the structure of
which was conﬁrmed by single-crystal X-ray analysis.20
The reaction sequence leading to clauszoline K (5) (Scheme
4), another popular target,22d,23 provided some insights into the
propensity of 2,3,4,9-tetrahydro-1H-carbazoles to engage in
alternate oxidation reactions.12a Thus, the palladium-catalyzed
Ullmann cross-coupling of the iodinated cyclohexenone 10
with the commercially available 2-iodonitroarene 22 proceeded
as anticipated to give the required arylated cyclohexenone 23
(80%), and this in turn engaged in the same type of reductive
cyclization reaction as seen before to give tetrahydrocarbazole
2411a,14 (65%). However, compound 24 proved rather prone to
oxidation, with the hydroperoxide 25 being formed in
increasing quantities when its precursor was allow to stand at
22 °C as a solution (in various solvents) left open to the
atmosphere. Compound 25, the structure of which was
established by single-crystal X-ray analysis,20 may arise through
a facially selective ene reaction between indole 24 and singlet
oxygen, the latter reactant (most likely) being produced
through the other (24) serving as a sensitizer. Despite the
ease of the conversion 24 → 25, the tetrahydrocarbazole was
readily dehydrogenated in the same manner as described in the
other instances reported herein, producing carbazole
269c,h,22d,23a,b in 88% yield. Unlike isomer 4, compound 26 is
not a naturally occurring material but is readily converted into
one, namely aldehyde 5 (clauszoline K) (66%), on treatment
with DDQ in aqueous methanol9h,23a,b at ambient temperature
for 4 h. The structure of compound 5 was conﬁrmed by single-
crystal X-ray analysis.20
The carbazole natural product mukonine (6), another
popular target compound,9a,12d,17a,24 carries both the methoxy
and carbomethoxy substituents in the same ring and so
requiring, as the ﬁrst step in the present synthesis, the
palladium-catalyzed Ullmann cross-coupling of the “parent” 2-
iodocyclohexeneone 9 with the readily obtained (see below)
tetrasubstituted arene 27 (Scheme 5), aﬀording the required 2-
arylated cyclohexenone 28, albeit in just 39% yield. Reductive
cyclization of compound 28 under standard conditions gave
tetrahydrocarbazole 29 (79%), which upon dehydrogenation
under the usual conditions aﬀorded mukonine (6) (66%) as a
white, crystalline solid. Once again, all of the derived spectral
Scheme 3. Synthesis of Glycozoline (4)
Scheme 4. Synthesis of Clauszoline K (5)
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data were fully consistent with the assigned structure as well as
those reported for the natural product, but ﬁnal conﬁrmation of
this followed from a single-crystal X-ray analysis.20 The arene
27 used in this sequence was prepared by ﬁrst brominating
commercially available methyl 4-amino-3-methoxybenzoate
with N-bromosuccinimide (NBS) and then oxidizing the
previously reported25 bromide to the corresponding nitro
compound (viz. 27) using m-chloroperbenzoic acid (mCPBA)
(see the Experimental Section for details).
The trisubstituted carbazole natural product karapinchamine
A (7), the subject of just one previous synthetic study,7e was
readily obtained (Scheme 6) by treating compound 26 with
boron tribromide so as to eﬀect cleavage of the methyl ether
moiety and then treating the product hydroxycarbazole 309h
(84%), as a solution in THF, with an excess of n-butyllithium
and then ca. 1.5 equiv of geranyl bromide. By such means
karapinchamine A (7) was obtained in 50% yield after column
chromatography. Interestingly, there was no evidence for the
formation of the isomeric O-geranylated product during the
course of this reaction. All of the spectral data acquired on
product 7 matched those recorded for the natural product (see
the Supporting Information for relevant spectral comparisons).
Monosubstituted carbazoles wherein the single substituent
derives from the arene coupling partner are also readily
available by the procedures reported here. Thus, as shown in
Scheme 7, cross-coupling of compounds 9 and 22 under the
usual conditions aﬀorded enone 3110,11b (91%), which on
subjection to reductive cyclization using hydrogen in the
presence of Raney nickel aﬀorded the tetrahydrocarazole
3210,11b,26 (76%). Dehydrogenation of compound 32 using
10% Pd on C in hot mesitylene then aﬀorded carbazole 86f,k,l,9j
(64%), the spectral data for which matched those reported
previously.
■ CONCLUSIONS
The procedures detailed here allow for the straightforward
preparation, in a fully regiocontrolled manner, of a range of
carbazoles carrying various combinations of substituents in
both the A and the C rings as well as on the nitrogen of the B
ring. Substitution patterns encountered in naturally occurring
and biologically active carbazoles appear to be completely
accessible using the methods described here. As a further
indication of the utility of the title protocol, it is worth noting
that carbazole 30 is an established precursor to the pyrano[3,2-
a]carbazole alkaloids isogirinimbine and mahanimbicine.9h In a
related vein, clauszoline K (5) is an established synthetic
precursor to the alkaloids clauszoline M and N (the
corresponding methyl ester and acid, respectively).22d,23a The
present study also serves to highlight the continued utility of
the palladium-catalyzed Ullmann cross-coupling reaction,27
especially when it is used in combination with reductive
cyclization protocols.28
■ EXPERIMENTAL SECTION
General Experimental Procedures. Unless otherwise speciﬁed,
proton (1H) and carbon (13C) NMR spectra were recorded at 18 °C
in base-ﬁltered CDCl3 on a spectrometer operating at 400 MHz for
proton and 100 MHz for carbon nuclei. 1H NMR data are recorded as
follows: chemical shift (δ) [multiplicity, coupling constant(s) J (Hz),
relative integral], where multiplicity is deﬁned as s = singlet, d =
doublet, t = triplet, q = quartet, and m = multiplet, or combinations of
the above. In relevant cases, the signal due to residual CHCl3
appearing at δH 7.26 and the central resonance of the CDCl3 “triplet”
Scheme 5. Synthesis of Mukonine (6)
Scheme 6. Synthesis of Karapinchamine A (7)
Scheme 7. Synthesis of 2-Methoxy-9H-carbazole (8)
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appearing at δC 77.0 were used to reference
1H and 13C NMR spectra,
respectively. Samples were analyzed by infrared spectroscopy (νmax) as
thin ﬁlms on KBr plates. Low- and high-resolution electron impact
(EI) mass spectra were recorded on a double-focusing, triple-sector
machine. Low- and high-resolution ESI mass spectra were recorded on
a triple-quadrupole mass spectrometer operating in either positive or
negative ion mode. Melting points are uncorrected. Analytical thin-
layer chromatography (TLC) was performed on aluminum-backed 0.2
mm thick silica gel 60 F254 plates. Eluted plates were visualized using a
254 nm UV lamp and/or by treatment with a suitable dip followed by
heating. These dips included phosphomolybdic acid/ceric sulfate/
sulfuric acid (concentrated)/water (37.5 g/7.5 g/37.5 g/720 mL),
potassium permanganate/potassium carbonate/5% sodium hydroxide
aqueous solution/water (3 g/20 g/5 mL/300 mL), and p-anisaldehyde
or vanillin/sulfuric acid (concentrated)/ethanol (15 g/2.5 mL/250
mL). Flash chromatographic separations were carried out following
protocols deﬁned by Still et al.29 with silica gel 60 (40−63 μm) as the
stationary phase and using the AR- or HPLC-grade solvents indicated.
The melting points of solids puriﬁed by such means were recorded
directly (i.e. after they had crystallized from the concentrated
chromatographic fractions). Starting materials, reagents, drying agents,
and other inorganic salts were generally commercially available and
were used as supplied. The copper powder used in the palladium-
catalyzed Ullmann cross-coupling reactions had a particle size of <75
μm. Tetrahydrofuran (THF), methanol, and dichloromethane were
dried using a solvent puriﬁcation system that is based upon a
technology originally described by Grubbs et al.30 Where necessary,
reactions were performed under a nitrogen atmosphere.
Speciﬁc Chemical Transformations. 2-Iodocyclohex-2-en-1-
one (9). Following a procedure reported by Johnson et al.,31 a
magnetically stirred solution of cyclohex-2-en-1-one (2.00 g, 20.8
mmol) in chloroform/pyridine (80 mL of a 1/1 v/v mixture)
maintained at 0 °C under a nitrogen atmosphere was treated, dropwise
over 2 h, with a solution of molecular iodine (18.5 g, 72.8 mmol) in
chloroform/pyridine (80 mL of a 1/1 v/v mixture). The ensuing
mixture was warmed to 22 °C, stirred at this temperature for 16 h then
diluted with diethyl ether (200 mL) and washed with water (1 × 100
mL), Na2S2O3 (2 × 100 mL of a 20% w/v aqueous solution), HCl (2
× 100 mL of a 1 M aqueous solution), water (2 × 100 mL) and brine
(1 × 100 mL) before being dried (MgSO4), ﬁltered, and concentrated
under reduced pressure to give a yellow oil. This was subjected to ﬂash
column chromatography (silica, 2/5/70 v/v/v ethyl acetate/dichloro-
methane/40−60 petroleum ether elution) to give, after concentration
of the appropriate fractions (Rf = 0.6 in 2/5/11 v/v/v ethyl acetate/
dichloromethane/40−60 petroleum ether), 2-iodocyclohex-2-en-1-one
919 (3.85 g, 83%) as a light yellow solid, mp 47−50 °C (lit.19 mp 47−
49 °C): 1H NMR (400 MHz, CDCl3) δ 7.77 (t, J = 4.4 Hz, 1H), 2.67
(m, 2H), 2.44 (m, 2H), 2.09 (m, 2H); 13C NMR (100 MHz, CDCl3) δ
192.3, 159.6, 104.0, 37.4, 30.1, 23.0; IR νmax 2949, 2939, 1675, 1585,
1421, 1314, 1120, 966, 914, 803, 703 cm−1; MS (EI, 70 eV) m/z 222
(M+•, 100%), 194 (75), 67 (40); HRMS M+• calcd for C6H7
127IO
221.9542, found 221.9540.
2-Iodo-4-methylcyclohex-2-en-1-one (10). A magnetically stirred
solution of 4-methylcyclohex-2-en-1-one32 (2.29 g, 20.8 mmol) in
chloroform/pyridine (80 mL of a 1/1 v/v mixture) maintained at 0 °C
under a nitrogen atmosphere was treated, dropwise over 2 h, with a
solution of molecular iodine (18.5 g, 72.8 mmol) in chloroform/
pyridine (80 mL of a 1/1 v/v mixture). The ensuing mixture was
warmed to 22 °C, stirred at this temperature for 16 h, and then diluted
with diethyl ether (200 mL) and washed with water (1 × 100 mL),
Na2S2O3 (2 × 100 mL of a 20% w/v aqueous solution), HCl (2 × 100
mL of a 1 M aqueous solution), water (2 × 100 mL), and brine (1 ×
100 mL) before being dried (MgSO4), ﬁltered, and concentrated
under reduced pressure to give a yellow oil. Subjection of this material
to ﬂash column chromatography (silica, 1/19 v/v ethyl acetate/40−60
petroleum ether elution) gave, after concentration of the appropriate
fractions (Rf = 0.5 in 1/5 v/v ethyl acetate/40−60 petroleum ether),
compound 1011b (3.98 g, 81%) as a light yellow oil: 1H NMR (400
MHz, CDCl3) δ 7.50 (d, J = 2.6 Hz, 1H), 2.66−2.56 (complex m, 2H),
2.48−2.39 (complex m, 1H), 2.07 (m, 1H), 1.64 (m, 1H), 1.08 (d, J =
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 191.8, 164.7, 102.9, 35.6,
35.5, 30.6, 19.7; IR νmax 2959, 2930, 2870, 1686, 1585, 1454, 1318,
1109, 790 cm−1; MS (EI, 70 eV) m/z 236 (M+•, 100%), 208 (25), 109
(75), 81 (50), 53 (60); HRMS M+• calcd for C7H9
127IO 235.9698,
found 235.9691.
2′-Nitro-4,5-dihydro-[1,1′-biphenyl]-2(3H)-one (12). A magneti-
cally stirred mixture of o-bromonitrobenzene (11) (941 mg, 4.7
mmol), 2-iodocyclohex-2-en-1-one (9) (470 mg, 2.1 mmol), copper
powder (673 mg, 10.6 g atom), CuI (605 mg, 3.2 mmol), and
Pd(dppf)Cl2·CH2Cl2 (87 mg, 0.1 mmol) in deoxygenated DMSO (21
mL) maintained under nitrogen was heated to 50 °C for 10 h. The
reaction mixture was then cooled to room temperature, quenched with
water (1 × 20 mL), diluted with ethyl acetate (1 × 40 mL), and
ﬁltered through a pad of diatomaceous earth and silica gel. The pad
and the solids thus retained were washed with ethyl acetate (2 × 50
mL), and the ﬁltrate was washed with water (2 × 100 mL) and then
brine (2 × 100 mL). The separated organic phase was dried (Na2SO4),
ﬁltered, and concentrated under reduced pressure to give a brown oil,
and subjection of this material to ﬂash chromatography (silica, 1/9 v/v
ethyl acetate/40−60 petroleum ether elution) gave, after concen-
tration of the appropriate fractions (Rf = 0.4 in 1/1 v/v ethyl acetate/
40−60 petroleum ether), compound 1210,11 (390 mg, 85%) as a light
yellow crystal, mp 96−99 °C (lit.10 mp 92−95 °C): 1H NMR (400
MHz, CDCl3) δ 7.99 (m, 1H), 7.58 (m, 1H), 7.46 (m, 1H), 7.25 (m,
1H), 7.00 (t, J = 4.2 Hz, 1H), 2.56 (m, 4H), 2.13 (m, 2H); 13C NMR
(100 MHz, CDCl3) δ 196.6, 148.7, 146.8, 139.4, 133.4, 132.2, 131.8,
128.8, 124.2, 38.4, 26.4, 22.7; IR νmax 2949, 2868, 1679, 1523, 1353,
1158, 859, 788, 751, 709 cm−1; MS (ESI, +ve) m/z 240 [(M + Na)+,
100%], 218 [(M + H)+, 10]; HRMS (M + H)+ calcd for C12H12NO3
218.0817, found 218.0825.
5-Methyl-2′-nitro-4,5-dihydro-[1,1′-biphenyl]-2(3H)-one (13). A
magnetically stirred mixture of o-bromonitrobenzene (11) (960 mg,
4.75 mmol), 2-iodo-4-methylcyclohex-2-en-1-one (10) (510 mg, 2.16
mmol), copper powder (687 mg, 10.80 g atom), CuI (617 mg, 3.24
mmol), and Pd(dppf)Cl2·CH2Cl2 (88 mg, 0.11 mmol) in
deoxygenated DMSO (22 mL) was heated to 50 °C under a nitrogen
atmosphere for 8 h. The reaction mixture was then cooled to room
temperature, quenched with water (20 mL), diluted with ethyl acetate
(40 mL), and then ﬁltered through a pad of diatomaceous earth and
silica gel. The pad and the solids thus retained were washed with ethyl
acetate (2 × 50 mL), and the organic phase associated with the ﬁltrate
was then washed with water (2 × 100 mL) and brine (2 × 100 mL)
before being dried (Na2SO4), ﬁltered, and concentrated under reduced
pressure to give a brown oil. Subjection of this material to ﬂash
chromatography (silica, 1/9 v/v ethyl acetate/40−60 petroleum ether
elution) gave, after concentration of the appropriate fractions (Rf = 0.5
in 1/1 v/v ethyl acetate/40−60 petroleum ether), compound 1311
(430 mg, 86%) as a light yellow oil: 1H NMR (400 MHz, CDCl3) δ
7.99 (m, 1H), 7.58 (m, 1H), 7.45 (m, 1H), 7.40 (d, J = 7.6 Hz, 1H),
6.80 (d, J = 1.6 Hz, 1H), 2.79 (broad s, 1H), 2.65−2.47 (complex m,
2H), 2.20 (m, 1H), 1.86−1.76 (complex m, 1H), 1.24 (m, 3H); 13C
NMR (100 MHz, CDCl3) δ 196.6, 152.3, 148.7, 138.4, 133.4, 132.1,
131.8, 128.9, 124.3, 37.2, 31.8, 30.7, 20.4; IR νmax 2960, 2872, 1681,
1525, 1354, 1159, 788, 750 cm−1; MS (ESI, +ve) m/z 254 [(M +
Na)+, 100%], 232 [(M + H)+, 10]; HRMS (M + Na)+ calcd for
C13H13NNaO3 254.0793, found 254.0799.
2,3,4,9-Tetrahydro-1H-carbazole (14). A magnetically stirred
mixture of compound 12 (100 mg, 0.46 mmol) and commercially
available W-2 Raney nickel (200 mg, washed twice with absolute
ethanol) in methanol (23 mL) was deoxygenated and then stirred
under an atmosphere of hydrogen at 22 °C for 18 h. After this time
and using an externally applied magnet to hold the solid associated
with the reaction mixture within the ﬂask, the supernatant liquid was
decanted and the retained solid washed with methanol (2 × 30 mL)
(Caution! Af ter these washings water should be added to the residual solid
so as to prevent a f ire.). The methanolic solutions were combined and
then concentrated under reduced pressure to give a white solid.
Subjection of this material to ﬂash column chromatography (silica, 1/9
v/v ethyl acetate/40−60 petroleum ether elution) gave, after
concentration of the appropriate fractions (Rf = 0.6 in 1/5 v/v ethyl
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acetate/40−60 petroleum ether), compound 1410,11,12b (50 mg, 64%)
as a white solid, mp 104−106 °C (lit.12b mp 104−106 °C): 1H NMR
[400 MHz, (CD3)2CO] δ 9.70 (broad s, 1H), 7.36 (d, J = 7.8 Hz, 1H),
7.26 (d, J = 7.8 Hz, 1H), 7.02−6.92 (complex m, 2H), 2.73 (t, J = 5.9
Hz, 2H), 2.68−2.65 (complex m, 2H), 1.92−1.81 (complex m, 4H);
13C NMR [100 MHz, (CD3)2CO] δ 137.1, 135.1, 128.8, 121.1, 119.1,
118.0, 111.3, 109.7, 24.2, 24.0, 23.8, 21.7; IR νmax 3396, 2926, 2849,
1467, 1450, 1439, 1325, 1304, 1233, 736, 635 cm−1; MS (ESI, +ve) m/
z 226 [(M + MeOH + Na)+, 100%], 188 (56), 172 [(M + H)+, 70];
HRMS (M + H)+ calcd for C12H14N 172.1126, found 172.1121.
3-Methyl-2,3,4,9-tetrahydro-1H-carbazole (15). A magnetically
stirred mixture of compound 13 (320 mg, 1.38 mmol) and
commercially available W-2 Raney nickel (640 mg, washed twice
with absolute ethanol) in methanol (69 mL) was deoxygenated and
then stirred under an atmosphere of hydrogen at 22 °C for 18 h. After
this time and using an externally applied magnet to hold the solid
associated with the reaction mixture within the ﬂask, the supernatant
liquid was decanted and the retained solid washed with methanol (2 ×
30 mL) (Caution! Af ter these washings water should be added to the
residual solid so as to prevent a f ire.). The methanolic solutions were
combined and then concentrated under reduced pressure to give a
white solid. Subjection of this material to ﬂash column chromatog-
raphy (silica, 1/9 v/v ethyl acetate/40−60 petroleum ether elution) to
give, after concentration of the appropriate fractions (Rf = 0.6 in 1/5
v/v ethyl acetate/40−60 petroleum ether), compound 1511,12b (148
mg, 58%) as a white solid, mp 98−100 °C (lit.12b mp 98−100 °C): 1H
NMR [400 MHz, (CD3)2CO] δ 9.70 (broad s, 1H), 7.36 (d, J = 7.6
Hz, 1H), 7.26 (d, J = 7.6 Hz, 1H), 7.02−6.92 (complex m, 2H), 2.83−
2.75 (complex m, 3H), 2.24 (m, 1H), 1.98−1.86 (complex m, 2H),
1.53 (m, 1H), 1.13 (d, J = 6.6 Hz, 3H); 13C NMR [100 MHz,
(CD3)2CO] δ 137.4, 134.9, 128.7, 121.1, 119.1, 118.0, 111.3, 109.7,
32.3, 30.6, 30.2, 23.4, 22.1; IR νmax 3405, 2949, 2923, 1620, 1467,
1326, 1232, 1009, 740 cm−1; MS (ESI, +ve) m/z 240 [(M + MeOH +
Na)+, 100%], 202 (45), 186 [(M + H)+, 30]; HRMS (M + H)+ calcd
for C13H16N 186.1283, found 186.1286.
9H-Carbazole (1). A magnetically stirred mixture of compound 14
(46 mg, 0.27 mmol) and 10 wt % Pd/C (46 mg) in mesitylene (5 mL)
was stirred at 150 °C under an atmosphere of nitrogen for 24 h. The
cooled reaction mixture was ﬁltered through ﬁlter paper, and the solids
thus retained were washed with ethyl acetate (2 × 15 mL). The ﬁltrate
was concentrated under reduced pressure, and the ensuing mixture of
product 1 and mesitylene was then subjected to ﬂash column
chromatography (silica, 1/19 v/v ethyl acetate/40−60 petroleum ether
elution). Concentration of the appropriate fractions (Rf = 0.6 in 1/5 v/
v ethyl acetate/40−60 petroleum ether) then gave compound 1 (25
mg, 55%) as a white, crystalline solid, mp 237−238 °C (lit.33 mp 245
°C): 1H NMR [400 MHz, (CD3)2CO] δ 10.32 (broad s, 1H), 8.11 (d,
J = 7.8 Hz, 2H), 7.51 (d, J = 8.1 Hz, 2H), 7.39 (m, 2H), 7.18 (m, 2H);
13C NMR [100 MHz, (CD3)2CO] δ 141.0, 126.4, 124.0, 120.9, 119.6,
111.7; IR νmax 3416, 3049, 1597, 1449, 1233, 928, 745, 722 cm
−1; MS
(ESI, − ve) m/z 166 [(M − H)−, 100%]; HRMS (M − H)− calcd for
C12H8N 166.0657, found 166.0656.
3-Methyl-9H-carbazole (2). A magnetically stirred mixture of
compound 15 (145 mg, 0.78 mmol) and 10 wt % Pd/C (145 mg) in
mesitylene (15 mL) was stirred at 150 °C under an atmosphere of
nitrogen for 24 h. The cooled reaction mixture was ﬁltered through
ﬁlter paper, and the solids thus retained were washed with ethyl acetate
(2 × 15 mL). The ﬁltrate was concentrated under reduced pressure,
and the ensuing mixture of product 2 and mesitylene was then
subjected to ﬂash column chromatography (silica, 1/19 v/v ethyl
acetate/40−60 petroleum ether elution) to give, after concentration of
the appropriate fractions (Rf = 0.6 in 1/3 v/v ethyl acetate/40−60
petroleum ether), compound 212b (80 mg, 57%) as a white solid, mp
200−202 °C (lit.12b mp 205−210 °C): 1H NMR [400 MHz,
(CD3)2CO] δ 10.17 (broad s, 1H), 8.07 (d, J = 7.8 Hz, 1H), 7.90
(s, 1H), 7.47 (d, J = 8.1 Hz, 1H), 7.39 (d, J = 8.2 Hz, 1H), 7.37−7.33
(complex m, 1H), 7.22 (dd, J = 8.2 and 1.2 Hz, 1H), 7.15 (m, 1H),
2.48 (s, 3H); 13C NMR [100 MHz, (CD3)2CO] δ 141.3, 139.2, 128.6,
127.7, 126.2, 124.2, 123.8, 120.8, 120.7, 119.4, 111.6, 111.4, 21.5; IR
νmax 3403, 3050, 2914, 2853, 1605, 1459, 1333, 1238, 805, 746, 726
cm−1; MS (ESI, −ve) m/z 180 [(M − H)−, 100%]; HRMS (M − H)−
calcd for C13H10N 180.0813, found 180.0804.
2′-Methoxy-5-methyl-6′-nitro-4,5-dihydro-[1,1′-biphenyl]-2(3H)-
one (17). A magnetically stirred mixture of 2-iodo-1-methoxy-3-
nitrobenzene (16)21 (341 mg, 1.22 mmol), 2-iodo-4-methylcyclohex-
2-en-1-one (10) (519 mg, 2.20 mmol), copper powder (311 mg, 4.89
g atom), CuI (349 mg, 1.83 mmol), and Pd(dppf)Cl2·CH2Cl2 (100
mg, 0.12 mmol) in deoxygenated DMSO (24 mL) was heated to 50
°C under a nitrogen atmosphere for 4 h. The reaction mixture was
then cooled to room temperature, quenched with water (10 mL),
diluted with ethyl acetate (20 mL), and then ﬁltered through a pad of
diatomaceous earth and silica gel. The pad and the solids thus retained
were washed with ethyl acetate (2 × 25 mL) and the organic phase
associated with the ﬁltrate then washed with water (2 × 50 mL) and
brine (2 × 50 mL) before being dried (Na2SO4), ﬁltered, and
concentrated under reduced pressure to give a brown oil. Subjection of
this material to ﬂash chromatography (silica, 2/5/40 v/v/v ethyl
acetate/dichloromethane/40−60 petroleum ether elution) gave, after
concentration of the appropriate fractions (Rf = 0.3 in 2/5/11 v/v/v
ethyl acetate/dichloromethane/40−60 petroleum ether), compound
17 (281 mg, 88%) as a light yellow solid, mp 94−96 °C: 1H NMR
(400 MHz, CDCl3) δ 7.53 (m, 1H), 7.40−7.10 (complex m, 2H), 6.63
(m, 1H), 3.78 (m, 3H), 2.76−2.48 (complex m, 3H), 2.24−2.14
(complex m, 1H), 1.90−1.76 (complex m, 1H), 1.20 (m, 3H); 13C
NMR (100 MHz, CDCl3) δ 196.9, 196.7, 158.1, 158.0, 153.7, 153.5,
150.3, 150.0, 133.0, 132.6, 129.1, 129.2, 121.5, 121.4, 116.1, 116.0,
115.6, 115.4, 56.7, 56.6, 37.3, 37.1, 32.0, 31.6, 30.9, 30.5, 20.4, 20.1; IR
νmax 2959, 1674, 1524, 1461, 1351, 1263, 1052, 794, 736 cm
−1; MS
(ESI, +ve) m/z 284 [(M + Na)+, 100%], 262 [(M + H)+, 15]; HRMS
(M + Na)+ calcd for C14H15NNaO4 284.0899, found 284.0896.
5-Methoxy-3-methyl-2,3,4,9-tetrahydro-1H-carbazole (18). A
magnetically stirred mixture of compound 17 (211 mg, 0.81 mmol)
and commercially available W-2 Raney nickel (422 mg, washed twice
with absolute ethanol) in methanol (40 mL) was deoxygenated and
then stirred under an atmosphere of hydrogen at 22 °C for 10 h. After
this time and using an externally applied magnet to hold the solid
associated with the reaction mixture within the ﬂask, the supernatant
liquid was decanted and the retained solid washed with methanol (2 ×
15 mL) (Caution! Af ter these washings water should be added to the
residual solid so as to prevent a f ire.). The methanolic solutions were
combined and then concentrated under reduced pressure to give a
white solid. Subjection of this material to ﬂash column chromatog-
raphy (silica, 1/3/30 v/v/v acetone/dichloromethane/40−60 petro-
leum ether elution) gave, after concentration of the appropriate
fractions (Rf = 0.5 in 1/3/6 v/v/v acetone/dichloromethane/40−60
petroleum ether), compound 1811a (125 mg, 72%) as a white solid,
mp 126−128 °C: 1H NMR [400 MHz, (CD3)2CO] δ 9.63 (broad s,
1H), 6.91−6.85 (complex m, 2H), 6.41 (dd, J = 6.5 and 1.9 Hz, 1H),
3.84 (s, 3H), 3.11 (dd, J = 16.0 and 4.7 Hz, 1H), 2.72 (m, 2H), 2.41
(m, 1H), 1.92−1.79 (complex m, 2H), 1.48 (m, 1H), 1.10 (d, J = 6.6
Hz, 3H); 13C NMR [100 MHz, (CD3)2CO] δ 155.1, 138.8, 132.8,
121.8, 118.6, 109.6, 105.1, 99.7, 55.3, 32.7, 32.1, 30.8, 23.4, 22.2; IR
νmax 3397, 2948, 2923, 2836, 1565, 1505, 1349, 1253, 1244, 1104, 775,
729 cm−1; MS (ESI, +ve) m/z 232 (100%), 216 [(M + H)+, 90];
HRMS (M + H)+ calcd for C14H18NO 216.1388, found 216.1393.
Glycoborine (3). A magnetically stirred mixture of compound 18
(50 mg, 0.23 mmol) and 10 wt % Pd/C (50 mg) in mesitylene (5 mL)
was stirred at 150 °C under an atmosphere of nitrogen for 24 h. The
cooled reaction mixture was ﬁltered through ﬁlter paper, and the solids
thus retained were washed with ethyl acetate (2 × 10 mL). The
combined ﬁltrates were concentrated under reduced pressure, and the
ensuing mixture of product 3 and mesitylene was then subjected to
ﬂash column chromatography (silica, 2/5/62 v/v/v ethyl acetate/
dichloromethane/40−60 petroleum ether elution) to give, after
concentration of the appropriate fractions (Rf = 0.4(5) in 2/5/11 v/
v/v ethyl acetate/dichloromethane/40−60 petroleum ether), com-
pound 33a (35 mg, 75%) as a white solid, mp 130−132 °C (lit.3a mp
132.0−134.6 °C): 1H NMR [400 MHz, (CD3)2CO] δ 10.17 (broad s,
1H), 8.07 (s, 1H), 7.36 (d, J = 8.2 Hz, 1H), 7.28 (t, J = 8.0 Hz, 1H),
7.17 (dd, J = 8.2 and 1.2 Hz, 1H), 7.08 (d, J = 8.2 Hz, 1H), 6.68 (d, J =
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8.0 Hz, 1H), 4.06 (s, 3H), 2.48 (s, 3H); 13C NMR [100 MHz,
(CD3)2CO] δ 157.1, 142.7, 138.4, 128.5, 127.2, 126.7, 123.6, 123.5,
113.0, 110.8, 104.7, 100.5, 55.6, 21.6; IR νmax 3402, 2917, 2838, 1608,
1585, 1506, 1459, 1347, 1260, 1098, 750, 723 cm−1; MS (ESI, +ve) m/
z 234 [(M + Na)+, 10%], 212 [(M + H)+, 100]; HRMS (M + H)+
calcd for C14H14NO 212.1075, found 212.1078.
5′-Methoxy-5-methyl-2′-nitro-4,5-dihydro-[1,1′-biphenyl]-2(3H)-
one (20). A magnetically stirred mixture of commercially available 2-
iodo-4-methoxynitrobenzene (19) (150 mg, 0.54 mmol), 2-iodo-4-
methylcyclohex-2-en-1-one (10) (229 mg, 0.97 mmol), copper
powder (137 mg, 2.15 g atom), CuI (154 mg, 0.81 mmol), and
Pd(dppf)Cl2·CH2Cl2 (44 mg, 0.05 mmol) in deoxygenated DMSO
(12 mL) was heated to 50 °C under a nitrogen atmosphere for 4 h.
The reaction mixture was then cooled to room temperature, quenched
with water (5 mL), diluted with ethyl acetate (10 mL), and then
ﬁltered through a pad of diatomaceous earth and silica gel. The pad
and the solids thus retained were washed with ethyl acetate (2 × 15
mL), and the separated organic phase associated with the ﬁltrate was
then washed with water (2 × 25 mL) and brine (2 × 25 mL) before
being dried (Na2SO4), ﬁltered, and concentrated under reduced
pressure to give a brown oil. Subjection of this material to ﬂash
chromatography (silica, 1/3/25 v/v/v acetone/dichloromethane/40−
60 petroleum ether elution) gave, after concentration of the
appropriate fractions [Rf = 0.5(5) in 1/3/6 v/v/v acetone/dichloro-
methane/40−60 petroleum ether], compound 20 (125 mg, 87%) as a
light yellow oil: 1H NMR (400 MHz, CDCl3) δ 8.09 (d, J = 9.1 Hz,
1H), 6.90 (dd, J = 9.1 and 2.6 Hz, 1H), 6.70 (m, 2H), 3.88 (s, 3H),
2.76−2.51 (complex m, 3H), 2.21 (m, 1H), 1.84 (m, 1H), 1.25 (d, J =
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 196.8, 163.4, 151.2,
141.7, 139.1, 135.2, 127.2, 117.2, 113.2, 56.1, 37.3, 31.8, 30.8, 20.5; IR
νmax 2953, 1681, 1578, 1512, 1340, 1298, 1238, 1026, 844 cm
−1; MS
(ESI, +ve) m/z 284 [(M + Na)+, 100%], 262 [(M + H)+, 10]; HRMS
(M + Na)+ calcd for C14H15NNaO4 284.0899, found 284.0890.
6-Methoxy-3-methyl-2,3,4,9-tetrahydro-1H-carbazole (21). A
magnetically stirred mixture of compound 20 (100 mg, 0.38 mmol)
and commercially available W-2 Raney nickel (200 mg, washed twice
with absolute ethanol) in methanol (19 mL) was deoxygenated and
then stirred under an atmosphere of hydrogen at 22 °C for 16 h. After
this time and using an externally applied magnet to hold the solid
associated with the reaction mixture within the ﬂask, the supernatant
liquid was decanted and the retained solid washed with methanol (2 ×
10 mL) (Caution! Af ter these washings water should be added to the
residual solid so as to prevent a f ire.). The methanolic solutions were
combined and then concentrated under reduced pressure to give a
white solid. Subjection of this material to ﬂash column chromatog-
raphy (silica, 1/3/20 v/v/v acetone/dichloromethane/40−60 petro-
leum ether elution) gave, after concentration of the appropriate
fractions (Rf = 0.6 in 1/3/6 v/v/v acetone/dichloromethane/40−60
petroleum ether), compound 2112b,d,22b (50 mg, 61%) as a white solid,
mp 108−109 °C: 1H NMR [400 MHz, (CD3)2CO] δ 9.52 (broad s,
1H), 7.14 (d, J = 8.6 Hz, 1H), 6.88 (s, 1H), 6.65 (d, J = 8.6 Hz, 1H),
3.78 (s, 3H), 2.80−2.73 (complex m, 3H), 2.20 (m, 1H), 1.95−1.85
(complex m, 2H), 1.52 (m, 1H), 1.12 (d, J = 6.5 Hz, 3H); 13C NMR
[100 MHz, (CD3)2CO] δ 154.6, 135.7, 132.5, 129.1, 111.8, 110.7,
109.6, 100.6, 55.8, 32.4, 30.6, 30.4, 23.6, 22.1; IR νmax 3401, 2947,
2909, 2830, 1591, 1481, 1454, 1431, 1210, 1137, 1030, 831, 796 cm−1;
MS (ESI, −ve) m/z 214 [(M − H)−, 100%]; HRMS (M − H)− calcd
for C14H16NO 214.1232, found 214.1235.
Glycozoline (4). A magnetically stirred mixture of compound 21
(44 mg, 0.20 mmol) and 10 wt % Pd/C (44 mg) in diphenyl ether (5
mL) was stirred at 210 °C under an atmosphere of nitrogen for 0.33 h.
The cooled reaction mixture was ﬁltered through ﬁlter paper, and the
solids thus retained were washed with ethyl acetate (2 × 5 mL). The
combined ﬁltrates were concentrated under reduced pressure, and the
ensuing mixture of product 4 and diphenyl ether was then subjected to
ﬂash column chromatography (silica, 1/9 v/v ethyl acetate/40−60
petroleum ether elution) to give, after concentration of the appropriate
fractions (Rf = 0.4 in 3/7 v/v ethyl acetate/40−60 petroleum ether),
compound 43a,15 (39 mg, 89%) as a white, crystalline solid, mp 180−
181 °C (lit.22b mp. = 177−178 °C): 1H NMR [400 MHz, (CD3)2CO]
δ 9.96 (broad s, 1H), 7.87 (s, 1H), 7.63 (d, J = 2.2 Hz, 1H), 7.36 (t, J =
8.5 Hz, 2H), 7.18 (d, J = 8.2 Hz, 1H), 7.00 (dd, J = 8.5 and 2.2 Hz,
1H), 3.88 (s, 3H), 2.47 (s, 3H); 13C NMR [100 MHz, (CD3)2CO] δ
154.5, 140.0, 136.1, 128.1, 127.7, 124.2(2), 124.2(0), 120.8, 115.6,
112.3, 111.5, 103.5, 56.1, 21.5; IR νmax 3398, 2928, 1493, 1470, 1457,
1208, 1148, 1033, 806 cm−1; MS (ESI, −ve) m/z 210 [(M − H)−,
60%], 195 (100); HRMS (M − H)− calcd for C14H12NO 210.0919,
found 210.0912.
4′-Methoxy-5-methyl-2′-nitro-4,5-dihydro-[1,1′-biphenyl]-2(3H)-
one (23). A magnetically stirred mixture of commercially available 1-
iodo-4-methoxy-2-nitrobenzene (22) (341 mg, 1.22 mmol), 2-iodo-4-
methylcyclohex-2-en-1-one (10) (519 mg, 2.20 mmol), copper
powder (311 mg, 4.89 g atom), CuI (349 mg, 1.83 mmol), and
Pd(dppf)Cl2·CH2Cl2 (100 mg, 0.12 mmol) in deoxygenated DMSO
(24 mL) was heated to 50 °C under a nitrogen atmosphere for 6 h.
The ensuing mixture was cooled to room temperature, quenched with
water (10 mL), diluted with ethyl acetate (20 mL), and then ﬁltered
through a pad of diatomaceous earth and silica gel. The pad and the
solids thus retained were washed with ethyl acetate (2 × 30 mL), and
the separated organic phase associated with the ﬁltrate was washed
with water (2 × 50 mL) and brine (2 × 50 mL) before being dried
(Na2SO4), ﬁltered, and concentrated under reduced pressure to give a
brown oil. Subjection of this material to ﬂash column chromatography
(silica, 2/5/64 v/v/v ethyl acetate/dichloromethane/40−60 petro-
leum ether elution) gave, after concentration of the appropriate
fractions (Rf = 0.4 in 2/5/11 v/v/v ethyl acetate/dichloromethane/
40−60 petroleum ether), compound 23 (256 mg, 80%) as a light
yellow oil: 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 2.3 Hz, 1H),
7.15−7.09 (complex m, 2H), 6.75 (dd, J = 2.7 and 1.1 Hz, 1H), 3.85
(s, 3H), 2.75 (m, 1H), 2.65−2.40 (complex m, 2H), 2.19 (m, 1H),
1.80 (m, 1H), 1.24 (d, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3)
δ 196.9, 159.7, 151.8, 149.2, 138.1, 132.7, 124.2, 119.7, 109.3, 56.0,
37.3, 31.8, 30.8, 20.5; IR νmax 2960, 1681, 1529, 1353, 1302, 1266,
1236, 1032, 800 cm−1; MS (ESI, +ve) m/z 284 [(M + Na)+, 100%],
262 [(M + H)+, 15]; HRMS (M + Na)+ calcd for C14H15NNaO4
284.0899, found 284.0901.
7-Methoxy-3-methyl-2,3,4,9-tetrahydro-1H-carbazole (24) and
trans-4a-Hydroperoxy-7-methoxy-3-methyl-2,3,4,4a-tetrahydro-
1H-carbazole (25). A magnetically stirred mixture of compound 23
(202 mg, 0.77 mmol) and commercially available W-2 Raney nickel
(404 mg, washed twice with absolute ethanol) in methanol (38 mL)
was deoxygenated and then stirred under an atmosphere of hydrogen
at 22 °C for 16 h. After this time and using an externally applied
magnet to hold the solid associated with the reaction mixture within
the ﬂask, the supernatant liquid was decanted and the retained solid
washed with methanol (2 × 20 mL) (Caution! Af ter these washings
water should be added to the residual solid so as to prevent a f ire.). The
methanolic solutions were combined and then concentrated under
reduced pressure to give a white solid. Subjection of this material to
ﬂash column chromatography (silica, 1/3/20 v/v/v acetone/dichloro-
methane/40−60 petroleum ether elution) gave two fractions, A and B.
Concentration of fraction A (Rf = 0.5 in 1/3/6 v/v/v acetone/
dichloromethane/40−60 petroleum ether) aﬀorded compound
2411a,14 (109 mg, 65%) as a white, crystalline solid, mp 130−132
°C: 1H NMR [400 MHz, (CD3)2CO] δ 9.50 (broad s, 1H), 7.22 (d, J
= 8.5 Hz, 1H), 6.83 (d, J = 2.2 Hz, 1H), 6.63 (dd, J = 8.5 and 2.2 Hz,
1H), 3.76 (s, 3H), 2.83−2.71 (complex m, 3H), 2.19 (m, 1H), 1.90
(m, 2H), 1.50 (m, 1H), 1.11 (d, J = 6.5 Hz, 3H); 13C NMR [100
MHz, (CD3)2CO] δ 156.6, 138.2, 133.4, 123.2, 118.5, 109.5, 108.6,
95.4, 55.7, 32.3, 30.6, 30.3, 23.5, 22.1; IR νmax 3390, 2909, 2835, 1630,
1570, 1496, 1459, 1335, 1291, 1203, 1157, 1029, 826, 805 cm−1; MS
(ESI, +ve) m/z 238 [(M + Na)+, 20%], 218 (100), 216 [(M + H)+,
90]; HRMS (M + H)+ calcd for C14H18NO 216.1388, found 216.1386.
Concentration of fraction B (Rf = 0.1 in 1/3/6 v/v/v acetone/
dichloromethane/40−60 petroleum ether) aﬀorded hydroperoxide 25
(15 mg, 8%) as a white, crystalline solid, mp 106−108 °C: 1H NMR
[700 MHz, (CD3)2CO] δ δ 10.81 (s, 1H), 7.26 (d, J = 8.0 Hz, 1H),
6.97 (d, J = 2.3 Hz, 1H), 6.71 (dd, J = 8.0 and 2.3 Hz, 1H), 3.82 (s,
3H), 2.82−2.76 (complex m, 1H), 2.68 (m, 1H), 2.43 (m, 1H), 2.14
(m, 2H), 1.13 (m, 1H), 0.95 (m, 1H), 0.92 (d, J = 6.6 Hz, 3H); 13C
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NMR [175 MHz, (CD3)2CO] δ 186.1, 162.2, 157.4, 131.5, 123.8,
110.8, 107.4, 92.3, 55.8, 44.4, 37.4, 30.3, 28.1, 21.0; IR νmax 3100, 2954,
2836, 1607, 1484, 1347, 1276, 1144, 1130, 1028, 845, 815 cm−1; MS
(ESI, +ve) m/z 270 [(M + Na)+, 100%], 248 [(M + H)+, 10]; HRMS
(ESI) (M + Na)+ calcd for C14H17NNaO3 270.1106, found 270.1107.
2-Methoxy-6-methyl-9H-carbazole (26). A magnetically stirred
mixture of compound 24 (100 mg, 0.46 mmol) and 10 wt % Pd/C
(100 mg) in diphenyl ether (10 mL) was stirred at 210 °C under an
atmosphere of nitrogen for 0.5 h. The cooled reaction mixture was
ﬁltered through ﬁlter paper, and the solids thus retained were washed
with ethyl acetate (2 × 10 mL). The combined ﬁltrates were
concentrated under reduced pressure, and the ensuing mixture of
product 269c,h,22d,23a,b and diphenyl ether was then subjected to ﬂash
column chromatography (silica, 2/5/60 v/v/v ethyl acetate/dichloro-
methane/40−60 petroleum ether elution) to give, after concentration
of the appropriate fractions (Rf = 0.4 in 2/5/11 v/v/v ethyl acetate/
dichloromethane/40−60 petroleum ether), compound 26 (87 mg,
88%) as a white solid, mp 229−231 °C (lit.9c mp 228−229 °C): 1H
NMR [400 MHz, (CD3)2CO] δ 10.03 (braod s, 1H), 7.92 (d, J = 8.6
Hz, 1H), 7.78 (s, 1H), 7.32 (d, J = 8.2 Hz, 1H), 7.11 (d, J = 8.2 Hz,
1H), 6.99 (d, J = 2.2 Hz, 1H), 6.77 (dd, J = 8.6 and 2.2 Hz, 1H), 3.85
(s, 3H), 2.46 (s, 3H); 13C NMR [100 MHz, (CD3)2CO] δ 160.0,
142.7, 139.3, 128.6, 126.3, 124.4, 121.5, 120.0, 117.6, 111.1, 108.6,
95.3, 55.7, 21.5; IR νmax 3391, 2962, 1615, 1460, 1310, 1261, 1164,
1035, 811 cm−1; MS (ESI, +ve) m/z 212 [(M + H)+, 100%]; HRMS
(M + H)+ calcd for C14H14NO 212.1075, found 212.1077.
Clauszoline K (5). A magnetically stirred solution of 2-methoxy-6-
methyl-9H-carbazole (26) (50 mg, 0.24 mmol) in methanol/water (16
mL of 10/1 v/v mixture) was treated with DDQ (226 mg, 0.99 mmol).
The ensuing mixture was stirred at room temperature for 4 h and then
diluted with ethyl acetate (30 mL). The separated organic phase was
washed with NaHCO3 (2 × 15 mL of a saturated aqueous solution),
water (1 × 30 mL), and brine (1 × 30 mL) before being dried
(Na2SO4), ﬁltered, and concentrated under reduced pressure. The
residue thus obtained was subjected to ﬂash chromatography (silica, 1/
3 v/v ethyl acetate/40−60 petroleum ether elution) to give, after
concentration of the appropriate fractions (Rf = 0.5 in 1/1 v/v ethyl
acetate/40−60 petroleum ether), compound 5 (35 mg, 66%) as a
yellow solid, mp 170−171 °C (lit.22d mp 184−185 °C): 1H NMR
[400 MHz, (CD3)2CO] δ 10.72 (broad s, 1H), 10.07 (s, 1H), 8.58 (s,
1H), 8.12 (d, J = 8.6 Hz, 1H), 7.88 (broadened d, J = 8.4 Hz, 1H),
7.59 (d, J = 8.4 Hz, 1H), 7.11 (d, J = 2.3 Hz, 1H), 6.91 (dd, J = 8.6 and
2.3 Hz, 1H), 3.89 (s, 3H); 13C NMR [100 MHz, (CD3)2CO] δ 192.0,
160.8, 144.8, 143.1, 130.1, 126.3, 124.4, 123.5, 122.2, 117.6, 111.8,
110.1, 96.0, 55.8; IR νmax 3306, 2923, 2849, 1667, 1604, 1569, 1456,
1317, 1159, 817, 807 cm−1; MS (ESI, −ve) m/z 224 [(M − H)−,
100%], 209 (54); HRMS (M − H)− calcd for C14H10NO2 224.0712,
found 224.0705.
Methyl 3-Bromo-5-methoxy-4-nitrobenzoate (27). Step i. A
magnetically stirred and ice-cold solution of methyl 4-amino-3-
methoxybenzoate (3.00 mg, 16.56 mmol) in chloroform (33 mL)
was treated, in portions over 1 h, with N-bromosuccinimide (NBS)
(2.95, 16.6 mmol). The ensuing mixture was stirred at 5−10 °C for 2 h
before being diluted with dichloromethane (1 × 200 mL) then washed
with Na2S2O3 (2 × 100 mL of a 20% w/v aqueous solution), water (2
× 100 mL), and brine (1 × 100 mL). The separated organic phase was
then dried (Na2SO4), ﬁltered, and concentrated under reduced
pressure. The residue thus obtained was subjected to ﬂash column
chromatography (silica, 3/17 v/v ethyl acetate/40−60 petroleum ether
elution) to give, after concentration of the appropriate fractions (Rf =
0.6 in 1/3 v/v ethyl acetate/40−60 petroleum ether), methyl 4-amino-
3-bromo-5-methoxybenzoate25 (3.70 g, 86%) as a yellow solid, mp
90−91 °C: 1H NMR (CDCl3, 400 MHz) δ 7.81 (s, 1H), 7.38 (s, 1H),
4.65 (broad s, 2H), 3.91 (s, 3H), 3.87 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 166.5, 146.3, 139.4, 127.1, 119.5, 109.9, 106.8, 56.2, 52.1; IR
νmax 3503, 3399, 1692, 1603, 1566, 1502, 1435, 1270, 1209, 1041, 995,
759 cm−1; MS (EI, 70 eV) m/z 261 and 259 (M+•, 98 and 100%,
respectively), 246 and 244 (both 65 and 63, respectively), 230 and 228
(both 54); HRMS M+• calcd for C9H10
79BrNO3 258.9844, found
258.9846.
Step ii. A magnetically stirred solution of methyl 4-amino-3-bromo-
5-methoxybenzoate (4.24 g, 16.31 mmol), obtained as described
immediately above, in 1,2-dichloroethane (163 mL) was treated with
m-chloroperbenzoic acid (mCPBA) (11.26 g of ca. 77% technical
grade material, 65.3 mmol). The resulting mixture was heated to 70 °C
for 14 h before being cooled, diluted with dichloromethane (150 mL),
washed with NaOH (2 × 150 mL of a 1 M aqueous solution) followed
by brine (1 × 100 mL), and then dried (MgSO4), ﬁltered, and
concentrated under reduced pressure. The residue thus obtained was
subjected to ﬂash column chromatography (silica, 1/8 v/v ethyl
acetate/40−60 petroleum ether elution) to give, after concentration of
the appropriate fractions (Rf = 0.5 in 1/2 v/v ethyl acetate/40−60
petroleum ether), methyl 3-bromo-5-methoxy-4-nitrobenzoate (27)
(4.13 g, 87%) as a yellow solid, mp 103−104 °C: 1H NMR (400 MHz,
CDCl3) δ 7.88 (d, J = 1.4 Hz, 1H), 7.65 (d, J = 1.4 Hz, 1H), 3.95(9)
(s, 3H), 3.95(6) (s, 3H); 13C NMR (100 MHz, CDCl3) δ 164.4, 151.8,
144.7, 133.1, 126.2, 113.8, 112.8, 57.1, 53.2; IR νmax 3097, 1730, 1540,
1406, 1289, 1248, 1037, 984, 822, 764 cm−1; MS (EI, 70 eV) m/z 291
and 289 (M+•, 98 and 100%, respectively) 259 and 257 (40 and 35,
respectively) 199 and 197 (60 and 50, respectively); HRMS M+• calcd
for C9H8
79BrNO5 288.9586, found 288.9587.
Methyl 5-Methoxy-6-nitro-2′-oxo-2′,3′,4′,5′-tetrahydro-[1,1′-bi-
phenyl]-3-carboxylate (28). A magnetically stirred mixture of methyl
3-bromo-5-methoxy-4-nitrobenzoate (28) (2.56 g, 8.82 mmol), 2-
iodocyclohex-2-en-1-one (9) (890 mg, 4.01 mmol), copper powder
(1.27 g, 20.04 g atom), CuI (1.15 g, 6.01 mmol), and Pd(dppf)Cl2·
CH2Cl2 (164 mg, 0.20 mmol) in deoxygenated DMSO (17 mL) was
heated to 50 °C under a nitrogen atmosphere for 28 h. The reaction
mixture was then cooled to room temperature, quenched with water
(20 mL), diluted with ethyl acetate (40 mL) and ﬁltered through a pad
of diatomaceous earth and silica gel. The pad and the solids thus
retained were washed with ethyl acetate (2 × 60 mL), and the organic
phase associated with the ﬁltrate was washed with water (2 × 100 mL)
and then brine (2 × 100 mL) before being dried (Na2SO4), ﬁltered,
and concentrated under reduced pressure to give a brown oil.
Subjection of this material to ﬂash column chromatography (silica, 1/9
v/v ethyl acetate/40−60 petroleum ether elution) gave, after
concentration of the appropriate fractions (Rf = 0.5 in 1/1 v/v ethyl
acetate/40−60 petroleum ether), compound 28 (478 mg, 39%) as a
yellow oil: 1H NMR (400 MHz, CDCl3) δ 7.67 (d, J = 1.3 Hz, 1H),
7.51 (d, J = 1.3 Hz, 1H), 7.05 (t, J = 4.2 Hz, 1H), 3.96 (s, 3H), 3.94 (s,
3H), 2.58−2.50 (complex m, 4H), 2.10 (m, 2H); 13C NMR (100
MHz, CDCl3) δ 196.1, 165.4, 151.2, 150.2, 143.3, 136.3, 132.4, 131.6,
124.2, 113.3, 57.0, 52.9, 38.3, 26.5, 22.7; IR νmax 2956, 2924, 1716,
1683, 1535, 1360, 1245, 1022, 838, 766 cm−1; MS (ESI, +ve) m/z 328
[(M + Na)+, 100%]; HRMS (M + Na)+ calcd for C15H15NNaO6
328.0797, found 328.0793.
Methyl 8-Methoxy-2,3,4,9-tetrahydro-1H-carbazole-6-carboxy-
late (29). A magnetically stirred mixture of compound 28 (400 mg,
1.31 mmol) and commercially available W-2 Raney nickel (800 mg,
washed twice with absolute ethanol) in methanol (65 mL) was
deoxygenated and then stirred under an atmosphere of hydrogen at 22
°C for 16 h. After this time and using an externally applied magnet to
hold the solid associated with the reaction mixture within the ﬂask, the
supernatant liquid was decanted and the retained solid washed with
methanol (2 × 40 mL) (Caution! Af ter these washings water should be
added to the residual solid so as to prevent a f ire.). The methanolic
solutions were combined and then concentrated under reduced
pressure to give a white solid. Subjection of this material to ﬂash
column chromatography (silica, 3/17 v/v ethyl acetate/40−60
petroleum ether elution) gave, after concentration of the appropriate
fractions (Rf = 0.6 in 1/2 v/v ethyl acetate/40−60 petroleum ether),
compound 29 (268 mg, 79%) as a white solid, mp 181−182 °C: 1H
NMR [400 MHz, (CD3)2CO] δ 10.15 (broad s, 1H), 7.81 (s, 1H),
7.25 (s, 1H), 3.96 (s, 3H), 3.86 (s, 3H), 2.77 (m, 2H), 2.70 (m, 2H),
1.92−1.82 (complex m, 4H); 13C NMR [100 MHz, (CD3)2CO] δ
168.5, 146.2, 136.6, 129.7, 129.4, 122.1, 114.8, 111.7, 102.5, 55.7, 51.8,
24.0, 23.9, 23.7, 21.6; IR νmax 3339, 2928, 2836, 1696, 1628, 1366,
1326, 1231, 1188, 993, 765 cm−1; MS (ESI, +ve) m/z 541 (65%), 282
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[(M + Na)+, 100]; HRMS (M + Na)+ calcd for C15H17NNaO3
282.1106, found 282.1105.
Mukonine (6). A magnetically stirred mixture of compound 29 (264
mg, 1.02 mmol) and 10 wt % Pd/C (264 mg) in mesitylene (20 mL)
was stirred at 150 °C under an atmosphere of nitrogen for 24 h. The
cooled reaction mixture was ﬁltered through ﬁlter paper, and the solids
thus retained were washed with ethyl acetate (2 × 20 mL). The ﬁltrate
was concentrated under reduced pressure and the ensuing mixture of
product 6 and mesitylene then subjected to ﬂash column
chromatography (silica, 1/19 v/v ethyl acetate/40−60 petroleum
ether elution) to give, after concentration of the appropriate fractions
(Rf = 0.5 in 1/3 v/v ethyl acetate/40−60 petroleum ether), compound
617 (171 mg, 66%) as a white solid, mp 196−198 °C (lit.17a mp 193−
195 °C): 1H NMR (400 MHz, CDCl3) δ 8.52 (broad s, 1H), 8.48 (s,
1H), 8.10 (d, J = 7.8 Hz, 1H), 7.60 (s, 1H), 7.49−7.43 (complex m,
2H), 7.28 (m, 1H), 4.05 (s, 3H), 3.98 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 168.1, 145.2, 139.6, 133.0, 126.5, 123.9, 123.7, 122.0, 120.9,
120.4, 116.4, 111.4, 106.8, 55.9, 52.2; IR νmax 3350, 2941, 1689, 1608,
1585, 1433, 1338, 1255, 758, 732 cm−1; MS (ESI, +ve) m/z 533
(28%), 278 [(M + Na)+, 100]; HRMS (M + Na)+ calcd for
C15H13NNaO3 278.0793, found 278.0792.
6-Methyl-9H-carbazol-2-ol (30). A magnetically stirred solution of
compound 26 (50 mg, 0.24 mmol) in dichloromethane (15 mL)
maintained at −78 °C under an atmosphere of nitrogen was treated,
dropwise, with BBr3 (470 μL of a 1 M solution in dichloromethane,
0.47 mmol). The resulting mixture was stirred at −78 °C for another 2
h and then warmed to −40 °C. After 2 h the reaction mixture was
recooled to −78 °C and a further portion of BBr3 (520 μL of a 1 M
solution in dichloromethane, 0.52 mmol) added dropwise. The
reaction mixture was then warmed to 22 °C, stirred at this temperature
for 11 h, cooled to 0 °C, and then quenched by the slow addition of
NaHCO3 (30 mL of a saturated aqueous solution). The resulting
mixture was extracted with dichloromethane (1 × 20 mL), and the
combined organic phases were washed with water (1 × 20 mL) and
brine (1 × 20 mL) before being dried (Na2SO4), ﬁltered, and
concentrated under reduced pressure. The residue thus obtained was
subjected to ﬂash chromatography (silica, 3/17 v/v ethyl acetate/40−
60 petroleum ether elution) to give, after concentration of the
appropriate fractions [Rf = 0.2(5) in 3/7 v/v ethyl acetate/40−60
petroleum ether], compound 309h (39 mg, 84%) as a white, crystalline
solid, mp 259−261 °C (lit.9h mp 230−233 °C): 1H NMR [400 MHz,
(CD3)2CO] δ 9.91 (broad s, 1H), 8.25 (s, 1H), 7.84 (d, J = 8.4 Hz,
1H), 7.74 (s, 1H), 7.28 (d, J = 8.2 Hz, 1H), 7.08 (d, J = 8.2 Hz, 1H),
6.90 (d, J = 2.1 Hz, 1H), 6.71 (dd, J = 8.4 and 2.1 Hz, 1H), 2.45 (s,
3H); 13C NMR (100 MHz, (CD3)2CO) δ 157.4, 143.0, 139.2, 128.4,
126.0, 124.7, 121.5, 119.8, 117.1, 110.9, 109.1, 97.4, 21.5; IR νmax 3403,
2922, 2853, 1633, 1616, 1490, 1459, 1296, 1026, 804 cm−1; MS (ESI,
−ve) m/z 196 [(M − H)−, 100%]; HRMS (M − H)− calcd for
C13H10NO 196.0762, found 196.0767.
Karapinchamine A (7). A magnetically stirred solution of
compound 30 (27 mg, 0.14 mmol) in anhydrous THF (7 mL)
maintained at 0 °C under a nitrogen atmosphere was treated,
dropwise, with n-BuLi (340 μL of a 1.6 M solution in n-hexane, 0.55
mmol). After 0.17 h, a solution of geranyl bromide (51 mg, 0.21
mmol) in THF (7 mL) was added dropwise over 0.5 h. The resulting
mixture was warmed to 22 °C, stirred at this temperature for 1.5 h,
then cooled to 0 °C and quenched with NH4Cl (15 mL of a saturated
aqueous solution). The resulting mixture was extracted with ethyl
acetate (2 × 30 mL), and the combined organic phases were washed
with water (1 × 20 mL) and brine (1 × 20 mL) before being dried
(Na2SO4), ﬁltered, and concentrated under reduced pressure. The
residue thus obtained was subjected to ﬂash chromatography (silica, 1/
9 v/v ethyl acetate/40−60 petroleum ether elution) to give, after
concentration of the appropriate fractions (Rf = 0.6 in 3/7 v/v ethyl
acetate/40−60 petroleum ether), compound 77e,18 (23 mg, 50%) as a
white solid, mp 118−119 °C (lit.7e mp 124.3−125.6 °C): 1H NMR
(400 MHz, CDCl3) δ 7.87 (d, J = 8.3 Hz, 1H), 7.78 (s, 1H), 7.23−
7.18 (complex m, 2H), 6.78 (d, J = 1.9 Hz, 1H), 6.70 (dd, J = 8.3 and
2.0 Hz, 1H), 5.24 (m, 1H), 5.02 (m, 1H), 4.88 (s, 1H), 4.79 (d, J = 6.1
Hz, 2H), 2.52 (s, 3H), 2.09−1.98 (complex m, 4H), 1.90 (s, 3H), 1.62
(s, 3H), 1.55 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 154.6, 142.2,
138.9, 138.7, 131.9, 128.4, 125.8, 123.9, 123.4, 121.2, 120.0, 119.6,
117.1, 108.4, 107.7, 95.2, 41.3, 39.5, 26.4, 25.8, 21.5, 17.8, 16.8; IR νmax
3278, 2922, 2855, 1635, 1610, 1487, 1471, 1348, 1171, 801 cm−1; MS
(ESI, +ve) m/z 356 [(M + Na)+, 100%], 334 [(M + H)+, 20]; HRMS
(M + Na)+ calcd for C23H27NNaO 356.1990, found 356.1994.
4′-Methoxy-2′-nitro-4,5-dihydro-[1,1′-biphenyl]-2(3H)-one (31).
A magnetically stirred mixture of 1-iodo-4-methoxy-2-nitrobenzene
(22) (912 mg, 3.27 mmol), 2-iodocyclohex-2-en-1-one (9) (330 mg,
1.49 mmol), copper powder (472 mg, 7.43 g atom), CuI (425 mg, 2.23
mmol), and Pd(dppf)Cl2·CH2Cl2 (61 mg, 0.07 mmol) in
deoxygenated DMSO (15 mL) was heated to 50 °C under a nitrogen
atmosphere for 10 h. The reaction mixture was then cooled to room
temperature, quenched with water (15 mL), diluted with ethyl acetate
(30 mL), and then ﬁltered through a pad of diatomaceous earth and
silica gel. The pad and the solids thus retained were washed with ethyl
acetate (2 × 40 mL), and the separated organic phase associated with
the ﬁltrate was washed with water (2 × 80 mL) and brine (2 × 80 mL)
before being dried (Na2SO4), ﬁltered, and concentrated under reduced
pressure to give a brown oil. Subjection of this material to ﬂash column
chromatography (silica, 2/5/44 v/v/v ethyl acetate/dichloromethane/
40−60 petroleum ether elution) gave, after concentration of the
appropriate fractions (Rf = 0.3 in 2/5/11 v/v/v ethyl acetate/
dichloromethane/40−60 petroleum ether), compound 3110,11b (334
mg, 91%) as a light yellow oil: 1H NMR [400 MHz, (CD3)2CO] δ
7.51 (d, J = 2.2 Hz, 1H), 7.28 (m, 2H), 7.10 (m, 1H), 3.92 (s, 3H),
2.58 (m, 2H), 2.46 (m, 2H), 2.09 (m, 2H); 13C NMR [100 MHz,
(CD3)2CO] δ 196.5, 160.5, 150.4, 147.5, 139.5, 133.6, 125.1, 120.0,
109.9, 56.4, 39.0, 27.0, 23.5; IR νmax 2945, 1678, 1525, 1496, 1353,
1232, 1035, 913, 830, 798 cm−1; MS (ESI, +ve) m/z 270 [(M + Na)+,
100%], 248 [(M + H)+, 10]; HRMS (M + Na)+ calcd for
C13H13NNaO4 270.0742, found 270.0739.
7-Methoxy-2,3,4,9-tetrahydro-1H-carbazole (32). A magnetically
stirred mixture of compound 31 (100 mg, 0.40 mmol) and
commercially available W-2 Raney nickel (200 mg, washed twice
with absolute ethanol) in methanol (23 mL) was deoxygenated and
then stirred under an atmosphere of hydrogen at 22 °C for 16 h. After
this time and using an externally applied magnet to hold the solid
associated with the reaction mixture within the ﬂask, the supernatant
liquid was decanted and the retained solid washed with methanol (2 ×
20 mL) (Caution! Af ter these washings water should be added to the
residual solid so as to prevent a f ire.). The methanolic solutions were
combined and then concentrated under reduced pressure to give a
white solid. Subjection of this material to ﬂash column chromatog-
raphy (silica, 1/3/20 v/v/v acetone/dichloromethane/40−60 petro-
leum ether elution) gave, after concentration of the appropriate
fractions (Rf = 0.4(5) in 1/3/6 v/v/v acetone/dichloromethane/40−
60 petroleum ether), compound 3210,11b,26 (62 mg, 76%) as a white,
crystalline solid, mp 138−139 °C (lit.10 mp 136−142 °C): 1H NMR
(400 MHz, CDCl3) δ 7.54 (broad s, 1H), 7.33 (d, J = 8.5 Hz, 1H),
6.80 (d, J = 2.2 Hz, 1H), 6.75 (dd, J = 8.5 and 2.2 Hz, 1H), 3.84 (s,
3H), 2.69 (m, 4H), 1.88 (m, 4H); 13C NMR (100 MHz, CDCl3) δ
155.9, 136.5, 132.9, 122.5, 118.3, 110.1, 108.4, 95.0, 56.0, 23.4,
23.3(5), 23.3(4), 21.1; IR νmax 3405, 2919, 2842, 1628, 1464, 1307,
1213, 1156, 1029, 826, 803 cm−1; MS (ESI, +ve) m/z 202 [(M + H)+,
100%]; HRMS (M + H)+ calcd for C13H16NO 202.1232, found
202.1230.
2-Methoxy-9H-carbazole (8). A magnetically stirred mixture of
compound 32 (40 mg, 0.20 mmol) and 10 wt % Pd/C (40 mg) in
mesitylene (5 mL) was stirred at 150 °C under an atmosphere of
nitrogen for 24 h. The cooled reaction mixture was ﬁltered through
ﬁlter paper, and the solids thus retained were washed with ethyl acetate
(2 × 10 mL). The combined ﬁltrates were concentrated under reduced
pressure, and the ensuing mixture of product 6 and mesitylene was
then subjected to ﬂash column chromatography (silica, 1/19 v/v ethyl
acetate/40−60 petroleum ether elution) to give, after concentration of
the appropriate fractions (Rf = 0.3 in 1/5 v/v ethyl acetate/40−60
petroleum ether), compound 86f,k,l,9j (25 mg, 64%) as a white,
crystalline solid, mp 227−228 °C (lit.6f mp 233−235 °C): 1H NMR
[400 MHz, (CD3)2CO] δ 10.18 (broad s, 1H), 7.97 (m, 2H), 7.44 (d,
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J = 8.1 Hz, 1H), 7.28 (t, J = 7.9 Hz, 1H), 7.13 (m, 1H), 7.03 (broad s,
1H), 6.80 (m, 1H), 3.86 (s, 3H); 13C NMR [100 MHz, (CD3)2CO] δ
160.1, 142.4, 141.0, 125.0, 124.2, 121.6, 120.0, 119.7, 117.7, 111.4,
108.8, 95.4, 55.7; IR νmax 3391, 2929, 1608, 1463, 1444, 1308, 1196,
1163, 1033, 818, 727 cm−1; MS (ESI, −ve) m/z 196 [(M − H)−,
100%]; HRMS (M − H)− calcd for C13H10NO 196.0762, found
196.0753.
X-ray Crystallographic Studies. Crystallographic Data. Com-
pound 1: C12H9N, Mr = 167.21, T = 150 K, orthorhombic, space
group Pnma, Z = 4, a = 7.6589(2) Å, b = 19.0353(5) Å, c = 5.6814(1)
Å; V = 828.29(3) Å3, Dx = 1.341 g cm
−3, 864 unique data (2θmax =
147.4°), R = 0.035 [for 795 reﬂections with I > 2.0σ(I)]; Rw = 0.058
(all data), S = 1.00.
Compound 2: C13H11N, Mr = 181.24, T = 150 K, monoclinic, space
group P21/c, Z = 4, a = 20.3990(8) Å, b = 5.7846(2) Å, c = 7.8899(3)
Å; β = 98.458(4)°; V = 920.88(6) Å3, Dx = 1.307 g cm−3, 1858 unique
data (2θmax = 147.8°), R = 0.057 [for 1748 reﬂections with I >
2.0σ(I)]; Rw = 0.096 (all data), S = 1.00.
Compound 3: C14H13NO, Mr = 211.26, T = 150 K, monoclinic,
space group P21/n, Z = 4, a = 11.4714(17) Å, b = 5.6130(6) Å, c =
16.915(2) Å; β = 95.648(12)°; V = 1083.9(2) Å3, Dx = 1.295 g cm−3,
2160 unique data (2θmax = 151.8°), R = 0.058 [for 1763 reﬂections
with I > 2.0σ(I)]; Rw = 0.164 (all data), S = 1.00.
Compound 4: C14H13NO, Mr = 211.26, T = 150 K, orthorhombic,
space group P212121, Z = 4, a = 6.4420(1) Å, b = 7.5921(1) Å, c =
21.9422(3) Å; V = 1073.16(3) Å3, Dx = 1.308 g cm
−3, 2166 unique
data (2θmax = 147.8°), R = 0.035 [for 2114 reﬂections with I >
2.0σ(I)]; Rw = 0.064 (all data), S = 1.00.
Compound 5: C14H11NO2, Mr = 225.25, T = 150 K, orthorhombic,
space group Pbca, Z = 8, a = 7.1367(1) Å, b = 13.2390(1) Å, c =
22.5108(2) Å; V = 2126.88(4) Å3, Dx = 1.407 g cm
−3, 2152 unique
data (2θmax = 147.8°), R = 0.033 [for 2089 reﬂections with I >
2.0σ(I)]; Rw = 0.058 (all data), S = 1.00.
Compound 6: C15H13NO3, Mr = 255.27, T = 150 K, monoclinic,
space group C2/c, Z = 8, a = 15.7767(2) Å, b = 9.4629(1) Å, c =
16.1402(2) Å; β = 91.7342(13)°; V = 2408.52(5) Å3, Dx = 1.408 g
cm−3, 3284 unique data (2θmax = 59.6°), R = 0.039 [for 2869
reﬂections with I > 2.0σ(I)]; Rw = 0.077 (all data), S = 1.00.
Compound 17: C14H15NO4, Mr = 261.27, T = 150 K, monoclinic,
space group P21/c, Z = 8, a = 21.5986(4) Å, b = 6.89910(11) Å, c =
17.6362(3) Å; β = 104.596(2)°; V = 2543.16(8) Å3, Dx = 1.365 g
cm−3, 5147 unique data (2θmax = 147.6°), R = 0.084 [for 4826
reﬂections with I > 2.0σ(I)]; Rw = 0.214 (all data), S = 1.12.
Compound 25: C14H17NO3, Mr = 247.29, T = 150 K, monoclinic,
space group P21/c, Z = 4, a = 14.6135(2) Å, b = 5.8504(1) Å, c =
14.6942 (2) Å; β = 96.2796(15)°; V = 1248.74(3) Å3, Dx = 1.315 g
cm−3, 2542 unique data (2θmax = 147.6°), R = 0.036 [for 2433
reﬂections with I > 2.0σ(I)]; Rw = 0.098 (all data), S = 1.00.
Structure Determination. The image for compound 6 was
measured on a diﬀractometer (Mo Kα, graphite monochromator, λ
= 0.71073 Å) ﬁtted with an area detector, and the data were extracted
using the DENZO/Scalepack package.34 Images for compounds 1−5,
17, and 25 were measured on a diﬀractometer (Cu Kα, mirror
monochromator, λ = 1.54184 Å) ﬁtted with an area detector and the
data extracted using the CrysAlis package.35 The structure solutions
for all eight compounds were solved by direct methods (SIR92)36 then
reﬁned using the CRYSTALS program package.37 Atomic coordinates,
bond lengths and angles, and displacement parameters have been
deposited at the Cambridge Crystallographic Data Centre (CCDC
nos. 1525166, 1525163, 1525164, 1525162, 1525167, 1525160,
1525161, and 1525165 for compounds 1−6, 17, and 25, respectively).
These data can be obtained free of charge via www.ccdc.cam.ac.uk/
data_request/cif, by e-mailing data_request@ccdc.cam.ac.uk, or by
contacting The Cambridge Crystallographic Data Centre, 12 Union
Road, Cambridge CB2 1EZ, U.K. (fax: + 44 1223 336033). Single-
crystal X-ray analyses of compound 1 have been reported previously.38
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Figure S1: Structure of compound 1 (CCDC 1525166) with labeling of selected atoms. Anisotropic displacement ellipsoids show 30% 
probability levels. Hydrogen atoms are drawn as circles with small radii. 
! S3 
 
 
 
Figure S2: Structure of compound 2 (CCDC 1525163) with labeling of selected atoms. Anisotropic displacement ellipsoids show 30% 
probability levels. Hydrogen atoms are drawn as circles with small radii. 
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Figure S3: Structure of compound 3 (CCDC 1525164) with labeling of selected atoms. Anisotropic displacement ellipsoids show 30% 
probability levels. Hydrogen atoms are drawn as circles with small radii. 
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Figure S4: Structure of compound 4 (CCDC 1525162) with labeling of selected atoms. Anisotropic displacement ellipsoids show 30% 
probability levels. Hydrogen atoms are drawn as circles with small radii.!!
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Figure S5: Structure of compound 5 (CCDC 1525167) with labeling of selected atoms. Anisotropic displacement ellipsoids show 30% 
probability levels. Hydrogen atoms are drawn as circles with small radii.!!
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Figure S6: Structure of compound 6 (CCDC 1525160) with labeling of selected atoms. Anisotropic displacement ellipsoids show 30% 
probability levels. Hydrogen atoms are drawn as circles with small radii.!!
! S8 
!
 
Figure S7: Structure of compound 17 (CCDC 1525161) with labeling of selected atoms. Only one of the two molecules present in the 
asymmetric unit is shown. There was some disordering of atoms C10A and C11A - only the major conformer is shown.  This conformer had an 
occupancy of 81.6%. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen atoms are drawn as circles with small radii. 
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Figure S8: Structure of compound 25 (CCDC 1525165) with labeling of selected atoms. Anisotropic displacement ellipsoids show 30% 
probability levels. Hydrogen atoms are drawn as circles with small radii.!!
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Table S1: Comparison of the 13C NMR Spectral Data Reported by Yoshikawa18 and Ma7e for Karapinchamine A  
with the Equivalent Data Recorded for Compound 7 Prepared by the Present Route 
δC 
(ex. Yoshikawa)a 
δC 
(ex. Ma)b 
δC 
(ex. Present Route)c 
Δδ  
δC(PRd) –δC(Y’kawa) 
154.5 154.2 154.6 0.1 
142.0 141.9 142.2 0.2 
138.8 138.7 138.9 0.1 
138.5 138.4 138.7 0.2 
131.8 131.7 131.9 0.1 
128.3 128.1 128.4 0.1 
125.6 125.5 125.8 0.2 
123.7 123.7 123.9 0.2 
123.3 123.1 123.4 0.1 
121.0 121.0 121.2 0.2 
119.8 119.6 120.0 0.2 
119.5 119.4 119.6 0.1 
117.0 116.8 117.1 0.1 
108.3 108.3 108.4 0.1 
107.5 107.5 107.7 0.2 
95.1 95.1 95.2 0.1 
41.2 40.9 41.3 0.1 
39.4 39.3 39.5 0.1 
27.2 26.2 26.4 0.2 
25.5 25.5 25.8 0.3 
21.4 21.3 21.5 0.1 
17.7 17.6 17.8 0.1 
16.6 16.4 16.8 0.2 
a Spectrum recorded in CDCl3 at 125 or 150 MHz; b Spectrum recorded in CDCl3 at 75 MHz; c Spectrum recorded  
in CDCl3 at 100 MHz; d PR = present route.     
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ABSTRACT: A cross-coupling/reductive cyclization protocol
has been employed in a uniﬁed approach to all four carbolines.
So, for example, the 2-nitropyridine 8, which is readily prepared
through an eﬃcient palladium-catalyzed Ullmann cross-coupling
reaction, is reductively cyclized under conventional conditions to
give 6,7,8,9-tetrahydro-α-carboline that is itself readily aromatized
to give α-carboline (1).
■ INTRODUCTION
The isomeric α-, β-, γ-, and δ-carbolines (1−4, respectively, in
Figure 1) are important heterocyclic rings systems.1 All are
found, albeit to varying extents, as key structural motifs in
natural products. They also feature in a wide range of
medicinally relevant compounds. The utility of their various
derivatives in materials science is a further focus of current
studies.2 The α-carboline framework (1) is encountered in a
limited number of naturally occurring anticancer agents and in
the neuro-protective alkaloid mescengricin.3 On the other hand,
synthetically derived α-carbolines have shown anxiolytic, anti-
inﬂammatory, central nervous system stimulating, and kinase
inhibitory properties.4 β-Carboline (2), itself a natural product
isolated from both plants and micro-organisms, is the most
well-known of the four systems and represents a key
substructure associated with, for example, the eudistomine
and manzamine classes of biologically active marine alkaloids.5
Many medicinal agents embodying this heterocyclic framework
have been identiﬁed.5,6 Derivatives of γ-carboline (3) have been
explored extensively as anticancer and anti-Alzheimer agents,7
while those associated with δ-carboline (4) have been studied,
inter alia, for their antibacterial and antitumor properties.1b,8 δ-
Carboline-containing alkaloids have been isolated from, for
example, various West and Central African plants that are
prized as sources of traditional medicines for treating malaria
and certain infectious diseases.1b
A multitude of methods has been established for the
synthesis of the carbolines, including classical ones involving
Graebe−Ullmann, Fischer indolization, Bischler−Napieralski,
and Pictet−Spengler reactions.9,10 Variations on the Cadogan
syntheses of carbazoles are also known,11 as are routes
involving the annulation of pyridines onto indoles,9,10,12
including through Diels−Alder and electrocyclization pro-
cesses. Generally speaking, though, “customized” approaches
are required for the assembly of each of the α-, β-, γ-, and δ-
carboline frameworks, thus prompting the search for more
general routes to them.13 There has been modest success in this
regard, with the most eﬀective route involving the cyclization of
anilinopyridines.13g−j Recently, Driver13i and Ray13j have each
reported variations on such methods that allow access to three
of the four frameworks. It is against this background that we
now detail a distinct, operationally simple, and likely ﬂexible
route to all four of the isomeric carbolines and highlight the
utility of this through the synthesis of the simple natural
product harman (5, Figure 2), a compound that displays anti-
HIV and antibacterial properties.14
■ RESULTS AND DISCUSSION
The pivotal steps associated with the uniﬁed approach to the
carbolines reported here are the palladium-catalyzed Ullmann
cross-coupling15 of 2-iodocyclohex-2-en-1-one16 with the
relevant halogenated nitropyridine and the reductive cyclization
of the ensuing 2-pyridylcyclohex-2-en-1-one to give the
corresponding 6,7,8,9-tetrahydrocarboline. Oxidation of these
tetrahydro compounds to their fully aromatic counterparts (viz.,
the carbolines) was readily accomplished using 10 wt %
palladium on carbon. This sequence mirrors that used in our
Received: February 10, 2017
Published: March 17, 2017
Figure 1. Isomeric α-, β-, γ-, and δ-carbolines (1−4).
Figure 2. β-Carboline alkaloid harman (5).
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recently reported syntheses of various carbazole-based natural
products, including glycoborine, glycozoline, clausazoline K,
mukonine, and karapinchamine A.17
The synthesis of α-carboline (1), as shown in Scheme 1, is
illustrative and starts with the palladium-catalyzed Ullmann
cross-coupling of the readily prepared17 2-iodocyclohex-2-en-1-
one (6) with commercially available 3-bromo-2-nitropyridine
(7), thus aﬀording the 2-pyridylcyclohex-2-en-1-one (8) in 82%
yield. In order to reduce the extent of homocoupling of the
pyridine in this reaction, the iodo enone 6 was treated with a
combination of copper metal, copper(I) iodide, and Pd(dppf)-
Cl2·CH2Cl2 in DMSO at 50 °C for 0.75 h prior the addition of
compound 7. Presumably this allows cupration of compound 6
to take place prior to a palladium-catalyzed cross-coupling
reaction with halide 7, thereby increasing the yields of product
8. The reductive cyclization of compound 8 was eﬀected using
hydrogen in the presence of catalytic amounts of 10 wt %
palladium on carbon (Pd/C) in methanol at room temperature
for 16 h, and this produced the 6,7,8,9-tetrahydrocarboline
(9)18 in 75% yield. In our hands, the oxidation19 of compound
9 to α-carboline (1)4a was best carried out by exposing the
former system to an equivalent mass of 10 wt % palladium on
carbon in diphenyl ether at 210 °C for 0.66 h. By such means
target 1 was obtained in 97% yield, and all of the spectral data
acquired on this material were in complete accord with the
assigned structure and matched those reported in the literature.
A single-crystal X-ray analysis was carried out on compound 1
and details of this are provided in the Experimental Section and
the Supporting Information (SI).
Given the use of 10 wt % palladium on carbon in both the
second and third steps of the reaction sequence, these could, in
principle, be “telescoped” to establish a one-pot process. To
date, however, we have not been able to identify conditions that
allow for this to be conducted in both an operationally superior
way and with better outcomes.
The synthesis of β-carboline (2) (Scheme 2) required 4-
iodo-3-nitropyridine (10)20 as a coupling partner, and this was
readily obtained by reacting the commercially available chloro
analogue with sodium iodide in acetonitrile (see the
Experimental Section for details). Cross-coupling of com-
pounds 6 and 10 proceeded smoothly under essentially the
same conditions as employed for the conversion 6 + 7→ 8 and
provided the anticipated coupling product 11 in 86% yield.
Reductive cyclization of compound 11 proceeded uneventfully
under the previously established conditions, and product 1221
(88%) was readily oxidized to target 2 (94%) upon brief
exposure to an equal mass of 10 wt % palladium on carbon in
hot diphenyl ether. Once again, all the spectral data acquired
for β-carboline (2) matched those reported22 previously. The
structure of compound 2 was also conﬁrmed by single-crystal
X-ray analysis.
The analogous synthesis of γ-carboline (3) is shown in
Scheme 3, and in this instance the required pyridine (13) was a
commercially available material. Reductive cyclization of the
cross-coupling product 14 (89%) produced from compound 6
and 13 proceeded as anticipated to give the tetrahydrocarboline
15,23 albeit in just 66% yield. Similarly, the oxidation of this last
compound under the previously employed conditions was less
eﬃcient than observed in the two previous cases, with
compound 324 being obtained in 77% yield. Once again, full
characterization of this product was undertaken, including by
single-crystal X-ray analysis.
The establishment of a uniﬁed approach to all the carbolines
followed from the successful synthesis of δ-carboline (4) by the
pathway shown in Scheme 4. So, as before, the palladium-
catalyzed Ullmann cross-coupling of iodo enone 6 with the
required and commercially available pyridine 16 proceeded
uneventfully to give product 17 (75%) that was reductively
cyclized in the usual manner to aﬀord the tetrahydrocarboline
1825 (65%). Oxidation of this last compound using an equal
Scheme 1. Synthesis of α-Carboline (1)
Scheme 2. Synthesis of β-Carboline (2)
Scheme 3. Synthesis of γ-Carboline (3)
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mass of 10 wt % palladium on carbon in hot diphenyl ether
then gave δ-carboline (4)26 (92%) that was subject to the usual
range of spectroscopic analyses, including a single-crystal X-ray
study.
In order to test the capacities of the above-mentioned
protocols to deliver substituted carbolines, the β-carboline-
based natural product harman (5, Figure 2) was targeted for
synthesis. The required pyridine was prepared by the route
shown in Scheme 5. Thus, commercially available 2-
methylpyridin-4-amine (19) was subjected to a Sandmeyer
reaction using water as the nucleophile, thus providing the
previously reported nitric acid salt27 20 of 2-methylpyridin-4-ol.
Aromatic nitration of this last compound could only be
achieved under rather forcing conditions, thus providing a 1:3
and inseparable mixture of pyridines 21 and 22 (70% combined
yield). Accordingly, this mixture was treated with POBr3 in
reﬂuxing toluene, thereby aﬀording what is presumed to be the
corresponding mixture of bromides 23 and 24 (92% combined
yield). These regioisomers could only be separated by HPLC
techniques but suﬃcient quantities of the pure form of the
latter could be accumulated by such means. The former
product (presumed to be compound 23) was not puriﬁed or
subject to any spectroscopic characterization.
With compound 24 in hand, the synthesis of harman (5) was
completed by the now standard pathway shown in Scheme 6.
Thus, palladium-catalyzed Ullmann cross-coupling of iodo
enone 6 with pyridine 24 delivered the required product 25 in
84% yield. Reductive cyclization of the last compound under
the usual conditions gave tetrahydroharman 2628 (83%), which
could be oxidized to the natural product 514,29 (91%) on
treatment with an equal mass of 10 wt % palladium on carbon
in hot diphenyl ether. Once again, all the spectral data,
including those derived from a single-crystal X-ray analysis,
acquired for compound 5 conﬁrmed the assigned structure, and
appropriate comparisons with those reported14 for the natural
product were entirely favorable.
■ CONCLUSIONS
The reaction sequences reported here should allow for the
rational/logical design of pathways to a wide range of α-, β-, γ-,
and δ-carbolines. This is all the more so given the increasingly
ready availability of a wide range of polysubstituted pyridines30
and 2-iodocyclohex-2-en-1-ones. For similar reasons, the
protocols deﬁned here should allow for ready access to a
wide range of azaindoles, compounds of considerable interest
from a medicinal chemistry perspective.31 Studies exploiting
such possibilities will be reported in due course.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Unless otherwise speciﬁed,
proton (1H) and carbon (13C) NMR spectra were recorded at 18 °C
in base-ﬁltered CDCl3 on a spectrometer operating at 400 MHz for
proton and 100 MHz for carbon nuclei. 1H NMR data are recorded as
follows: chemical shift (δ) [multiplicity, coupling constant(s) J (Hz),
relative integral], where multiplicity is deﬁned as s = singlet; d =
doublet; t = triplet; q = quartet; m = multiplet or combinations of the
above. In relevant cases, the signal due to residual CHCl3 appearing at
δH 7.26 and the central resonance of the CDCl3 “triplet” appearing at
δC 77.0 were used to reference
1H and 13C NMR spectra, respectively.
Samples were analyzed by infrared spectroscopy (νmax) as thin ﬁlms
on KBr plates. Low- and high-resolution electron impact (EI) mass
spectra were recorded on a double-focusing, triple-sector machine.
Low- and high-resolution ESI mass spectra were recorded on a triple-
quadrupole mass spectrometer operating in positive ion mode. Melting
points are uncorrected. Analytical thin-layer chromatography (TLC)
was performed on aluminum-backed 0.2 mm thick silica gel 60 F254
plates. Eluted plates were visualized using a 254 nm UV lamp and/or
by treatment with a suitable dip followed by heating. These dips
included phosphomolybdic acid/ceric sulfate/sulfuric acid (concd)/
water (37.5 g/7.5 g/37.5 g/720 mL), potassium permanganate/
potassium carbonate/5% sodium hydroxide aqueous solution/water (3
g/20 g/5 mL/300 mL), and p-anisaldehyde or vanillin/sulfuric acid
Scheme 4. Synthesis of δ-Carboline (4)
Scheme 5. Route to the Trisubstituted Pyridine 24 Required
for the Synthesis of the β-Carboline Alkaloid Harman (5)
Scheme 6. Completion of the Synthesis of Harman (5)
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(concd)/ethanol (15 g/2.5 mL/250 mL). Flash chromatographic
separations were carried out following protocols deﬁned by Still et al.32
with silica gel 60 (40−63 μm) as the stationary phase and using the
AR- or HPLC-grade solvents indicated. The melting points of solids
puriﬁed by such means were recorded directly (i.e., after they had
crystallized from the concentrated chromatographic fractions). Starting
materials, reagents, drying agents, and other inorganic salts were
generally commercially available and were used as supplied. The
copper powder used in the palladium-catalyzed Ullmann cross-
coupling reactions had a particle size of <75 μm. Tetrahydrofuran
(THF), methanol, and dichloromethane were dried using a solvent
puriﬁcation system that is based upon a technology originally
described by Grubbs et al.33 Where necessary, reactions were
performed under a nitrogen atmosphere by subjecting the relevant
solution to reduced pressure for several minutes and then admitting
nitrogen. This process was repeated three times.
Speciﬁc Chemical Transformations. 2-(2-Nitropyridin-3-yl)-
cyclohex-2-en-1-one (8). A magnetically stirred mixture of 2-
iodocyclohex-2-en-1-one (6)16 (2.63 g, 11.82 mmol), copper powder
(1.50 g, 23.65 mmol), CuI (1.69 g, 8.87 mmol), and Pd(dppf)Cl2·
CH2Cl2 (483 mg, 0.59 mmol) in degassed DMSO (118 mL) was
heated at 50 °C under a nitrogen atmosphere for 0.75 h. After this
time, a solution of commercially available 3-bromo-2-nitropyridine (7)
(1.20 g, 5.91 mmol) in degassed DMSO (30 mL) was added to the
reaction mixture over 1.5 h. After a further 4 h, the reaction mixture
was cooled, quenched with water (30 mL), and then diluted with ethyl
acetate (50 mL). The ensuing mixture was ﬁltered through a pad
comprised of a mixture of diatomaceous earth and silica gel. The solids
thus retained were rinsed with ethyl acetate (2 × 50 mL), and the
separated organic phase associated with the combined ﬁltrates was
washed with water (2 × 100 mL) and then brine (2 × 100 mL) before
being dried (Na2SO4), ﬁltered, and concentrated under reduced
pressure to give a brown oil. Subjection of this material to ﬂash column
chromatography (silica, 1:3:11 v/v/v acetone/dichloromethane/40−
60 petroleum ether elution) gave, after concentration of the
appropriate fractions (Rf = 0.2 in 1:1 v/v ethyl acetate/40−60
petroleum ether), compound 8 (1.06 g, 82%) as a light-brown solid:
mp = 115−116 °C; 1H NMR (400 MHz, CDCl3) δ 8.52 (dd, J = 4.7
and 1.7 Hz, 1H), 7.74 (dd, J = 7.6 and 1.7 Hz, 1H), 7.60 (dd, J = 7.6
and 4.7 Hz, 1H), 7.08 (t, J = 4.2 Hz, 1H), 2.60 (m, 4H), 2.15 (m, 2H);
13C NMR (100 MHz, CDCl3) δ 196.0, 157.0, 148.5, 147.8, 141.7,
137.2, 128.1, 126.7, 38.2, 26.5, 22.6; IR νmax 2950, 1679, 1540, 1405,
1366, 975, 864, 810, 707 cm−1; MS (ESI, +ve) m/z 241 [(M + Na)+,
100%]; HRMS m/z (M + Na)+ calcd for C11H10N2NaO3 241.0589,
found 241.0591.
6,7,8,9-Tetrahydro-5H-pyrido[2,3-b]indole (9). A magnetically
stirred mixture of compound 8 (30 mg, 0.14 mmol) and 10 wt %
Pd/C (12 mg) in degassed methanol (7 mL) was maintained under an
atmosphere of hydrogen for 16 h at 22 °C and then ﬁltered, and the
solids thus retained were washed with methanol (20 mL). The
combined ﬁltrates were concentrated under reduced pressure and the
white solid thus obtained was subjected to ﬂash column chromatog-
raphy (silica, 1:4 v/v ethyl acetate/40−60 petroleum ether elution).
Concentration of the appropriate fractions (Rf = 0.7 in ethyl acetate)
then gave compound 918 (18 mg, 75%) as a white, crystalline solid: mp
= 155−156 °C (lit.18 mp = 155−156 °C); 1H NMR (400 MHz,
CDCl3) δ 10.65 (m, 1H), 8.19 (d, J = 4.3 Hz, 1H), 7.75 (dd, J = 7.7
and 1.3 Hz, 1H), 7.01 (dd, J = 7.7 and 4.3 Hz, 1H), 2.84 (t, J = 6.0 Hz,
2H), 2.70 (m, 2H), 1.98−1.86 (complex m, 4H); 13C NMR (100
MHz, CDCl3) δ 148.9, 140.8, 135.4, 125.7, 120.8, 115.1, 108.4,
23.3(4), 23.2(8), 23.1, 20.8; IR νmax 3149, 3075, 2921, 2846, 1587,
1418, 1289, 786, 765, 677 cm−1; MS (ESI, +ve) m/z 173 [(M + H)+,
100%]; HRMS m/z (M + H)+ calcd for C11H13N2 173.1079, found
173.1078.
9H-Pyrido[2,3-b]indole (α-Carboline, 1). A magnetically stirred
mixture of compound 9 (20 mg, 0.12 mmol) and 10 wt % Pd/C (20
mg) in diphenyl ether (15 mL) maintained under a nitrogen
atmosphere was heated at 210 °C for 0.66 h. The reaction mixture
was then cooled to room temperature and ﬁltered (through ﬁlter
paper), and the solids so retained were washed with ethyl acetate (2 ×
15 mL). The combined ﬁltrates were concentrated under reduced
pressure, and the residue thus obtained was subjected to ﬂash column
chromatography (silica, 0:1→ 1:4 v/v ethyl acetate/40−60 petroleum
ether gradient elution). Concentration of the appropriate fractions (Rf
= 0.2 in 1:1 v/v ethyl acetate/40−60 petroleum ether) gave compound
14a (19 mg, 97%) as a white, crystalline solid: mp = 200−202 °C (lit.4a
mp = 215−217 °C); 1H NMR (400 MHz, CD3OD) δ 8.44 (dd, J = 7.7
and 1.5 Hz, 1H), 8.34 (dd, J = 4.9 and 1.2 Hz, 1H), 8.09 (d, J = 7.9 Hz,
1H), 7.52 (d, J = 8.1 Hz, 1H), 7.48−7.44 (complex m, 1H), 7.26−7.19
(complex m, 2H) (signal due to N−H group proton not observed);
13C NMR (100 MHz, CD3OD) δ 152.9, 146.1, 140.6, 129.9, 128.0,
122.0, 121.9, 121.0, 118.0, 116.1, 112.3; IR νmax 3048, 2984, 2906,
1600, 1587, 1572, 1455, 1411, 1274, 998, 767, 736 cm−1; MS (ESI,
+ve) m/z 169 [(M + H)+, 100%]; HRMS m/z (M + H)+ calcd for
C11H9N2 169.0766, found 169.0768.
4-Iodo-3-nitropyridine (10). A magnetically stirred solution of
commercially available 4-chloro-3-nitropyridine (1.00 g, 6.31 mmol) in
acetonitrile (126 mL) maintained at ambient temperatures was treated
with sodium iodide (17.02 g, 113.55 mmol). The ensuing mixture was
heated under reﬂux for 2 h and then cooled to 22 °C and diluted with
ethyl acetate (200 mL). The resulting solution was washed with
Na2CO3 (1 × 100 mL of a saturated aqueous solution), Na2SO3 (1 ×
50 mL of a saturated solution), water (1 × 200 mL), and brine (1 ×
100 mL) before being dried (Na2SO4,), ﬁltered, and then concentrated
under reduced pressure. The residue thus obtained was subjected to
ﬂash column chromatography (silica, 1:19 v/v ethyl acetate/40−60
petroleum ether elution) to give, after concentration of the appropriate
fractions (Rf = 0.5 twice in 1:5 v/v ethyl acetate/40−60 petroleum
ether), 4-iodo-3-nitropyridine (10)20 (1.46 g, 92%) as a light-yellow
solid: mp = 80−82 °C; 1H NMR (400 MHz, CDCl3) δ 9.04 (broad s,
1H), 8.35 (d, J = 5.1 Hz, 1H), 8.03 (d, J = 5.1 Hz, 1H); 13C NMR
(100 MHz, CDCl3) δ 152.5, 149.6, 145.9, 136.5, 98.5; IR νmax 1572,
1540, 1521, 1357, 1223, 1058, 835, 657 cm−1; MS (EI, 70 eV) m/z
250 (M+•, 100%), 204 (70), 177 (60); HRMS m/z M+• calcd for
C5H3
127IN2O2 249.9239, found 249.9236.
2-(3-Nitropyridin-4-yl)cyclohex-2-en-1-one (11). A magnetically
stirred mixture of 2-iodocyclohex-2-en-1-one (6) (888 mg, 4.00
mmol), copper powder (508 mg, 8.00 mmol), CuI (571 mg, 3.00
mmol), and Pd(dppf)Cl2·CH2Cl2 (163 mg, 0.20 mmol) in degassed
DMSO (40 mL) was heated at 50 °C under a nitrogen atmosphere for
0.75 h. After this time a solution of compound 10 (500 mg, 2.00
mmol) in degassed DMSO (10 mL) was added to the reaction mixture
over 1 h. After a further 0.75 h, the reaction mixture was cooled,
quenched with water (10 mL), and then diluted with ethyl acetate (15
mL). The ensuing mixture was ﬁltered through a pad comprised of a
mixture of diatomaceous earth and silica gel. The solids thus retained
were rinsed with ethyl acetate (2 × 15 mL), and the separated organic
phase associated with the combined ﬁltrates was washed with water (2
× 30 mL) and then brine (2 × 30 mL) before being dried (Na2SO4),
ﬁltered, and concentrated under reduced pressure to give a brown oil.
This was subjected to ﬂash column chromatography (silica, 1:3:10 v/
v/v acetone/dichloromethane/40−60 petroleum ether elution) and
gave, after concentration of the appropriate fractions [Rf = 0.1(5) in
1:1 v/v ethyl acetate/40−60 petroleum ether], compound 11 (374
mg, 86%) as a light-yellow solid: mp = 105−107 °C; 1H NMR (400
MHz, CDCl3) δ 9.18 (s, 1H), 8.78 (d, J = 4.9 Hz, 1H), 7.22 (d, J = 4.9
Hz, 1H), 7.13 (t, J = 4.2 Hz, 1H), 2.63−2.57 (complex m, 4H), 2.19−
2.13 (complex m, 2H); 13C NMR (100 MHz, CDCl3) δ 195.5, 153.9,
148.7, 145.3, 145.0, 140.0, 137.5, 125.6, 38.2, 26.5, 22.5; IR νmax 2948,
1679, 1600, 1542, 1523, 1357, 1217, 1159, 1121, 851, 716 cm−1; MS
(ESI, +ve) m/z 219 [(M + H)+, 100%]; HRMS m/z (M + H)+ calcd
for C11H11N2O3 219.0770, found 219.0768.
6,7,8,9-Tetrahydro-5H-pyrido[3,4-b]indole (12). A magnetically
stirred mixture of compound 11 (190 mg, 0.87 mmol) and 10 wt %
Pd/C (76 mg) in degassed methanol (44 mL) was maintained under
an atmosphere of hydrogen for 16 h at 22 °C and then ﬁltered, and the
solids thus retained were washed with methanol (100 mL). The
combined ﬁltrates were concentrated under reduced pressure, and the
white solid thus obtained was subjected to ﬂash column chromatog-
raphy (silica, 1:4 v/v methanol/dichloromethane elution) to give, after
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concentration of the appropriate fractions [Rf = 0.3(5) in 1:1 v/v
methanol/dichloromethane], compound 1221 (132 mg, 88%) as a
white, crystalline solid: mp = 163−164 °C (lit.21 mp = 199−200 °C);
1H NMR (700 MHz, CD3OD) δ 8.49 (broad s, 1H), 7.97 (broad s,
1H), 7.36 (d, J = 4.9 Hz, 1H), 2.77 (t, J = 6.0 Hz, 2H), 2.65 (t, J = 6.0
Hz, 2H), 1.92−1.83 (complex m, 4H) (signal due to N−H group
proton not observed); 13C NMR (175 MHz, CD3OD) δ 142.2, 136.9,
134.5, 134.2, 132.6, 113.7, 110.4, 24.2(2), 24.2(0), 24.0, 21.6; IR νmax
3143, 3040, 2926, 2850, 2839, 1569, 1471, 1442, 1359, 1142, 1030,
808 cm−1; MS (ESI, +ve) m/z 173 [(M + H)+, 100%]; HRMS m/z
(M + H)+ calcd for C11H13N2 173.1079, found 173.1078.
9H-Pyrido[3,4-b]indole (β-Carboline, 2). A magnetically stirred
mixture of compound 12 (20 mg, 0.12 mmol) and 10 wt % Pd/C (20
mg) in diphenyl ether (15 mL) maintained under a nitrogen
atmosphere was heated at 210 °C for 0.66 h. The reaction mixture
was then cooled to room temperature and ﬁltered (through ﬁlter
paper), and the solids so retained were washed with ethyl acetate (2 ×
15 mL). The combined ﬁltrates were concentrated under reduced
pressure, and the residue thus obtained was subjected to ﬂash column
chromatography (silica, 0:1→ 1:1 v/v ethyl acetate/40−60 petroleum
ether gradient elution) to give, after concentration of the appropriate
fractions (Rf = 0.5 in 1:2 v/v methanol/dichloromethane), compound
222 (18 mg, 94%) as a white, crystalline solid: mp = 210−211 °C (lit.22
mp = 199−201 °C); 1H NMR (400 MHz, CD3OD) δ 8.79 (s, 1H),
8.27 (d, J = 5.3 Hz, 1H), 8.18 (d, J = 8.0 Hz, 1H), 8.08 (d, J = 5.3 Hz,
1H), 7.56 (m, 2H), 7.29−7.23 (complex m, 1H) (signal due to N−H
group proton not observed); 13C NMR (100 MHz, CD3OD) δ 142.7,
138.4, 137.8, 134.1, 130.4, 129.7, 122.7, 122.2, 120.8, 116.1, 112.8; IR
νmax 3134, 3052, 2963, 2754, 1628, 1449, 1331, 1245, 746, 732 cm
−1;
MS (ESI, +ve) m/z 191 [(M + Na)+, 70%], 169 [(M + H)+, 100];
HRMS m/z (M + H)+ calcd for C11H9N2 169.0766, found 169.0766.
2-(4-Nitropyridin-3-yl)cyclohex-2-en-1-one (14). A magnetically
stirred mixture of 2-iodocyclohex-2-en-1-one (6) (2.19 g, 9.85 mmol),
copper powder (1.26 g, 19.70 mmol), CuI (1.41 g, 7.39 mmol), and
Pd(dppf)Cl2·CH2Cl2 (400 mg, 0.49 mmol) in degassed DMSO (98
mL) was heated at 50 °C under a nitrogen atmosphere for 0.75 h.
After this time, a solution of compound 13 (1.00 g, 4.93 mmol) in
degassed DMSO (25 mL) was added to the reaction mixture over 1.5
h. After a further 4 h, the reaction mixture was cooled, quenched with
water (20 mL), and then diluted with ethyl acetate (1 × 30 mL). The
ensuing mixture was ﬁltered through a pad comprised of a mixture of
diatomaceous earth and silica gel. The solids thus retained were rinsed
with ethyl acetate (2 × 30 mL), and the separated organic phase
associated with the combined ﬁltrates was washed with water (2 × 60
mL) and then brine (2 × 60 mL) before being dried (Na2SO4),
ﬁltered, and concentrated under reduced pressure to give a brown oil.
Subjection of this material to ﬂash column chromatography (silica,
1:3:11 v/v/v acetone/dichloromethane/40−60 petroleum ether
elution) gave, after concentration of the appropriate fractions (Rf =
0.2 in 1:3:6 v/v/v acetone/dichloromethane/40−60 petroleum ether),
compound 14 (956 mg, 89%) as a light-brown solid: mp = 94−95 °C;
1H NMR (400 MHz, CDCl3) δ 8.82 (d, J = 5.3 Hz, 1H), 8.61 (s, 1H),
7.81 (d, J = 5.3 Hz, 1H), 7.17 (t, J = 4.2 Hz, 1H), 2.66−2.58 (complex
m, 4H), 2.18 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 196.1, 154.1,
152.8, 151.4, 148.6, 136.0, 125.4, 116.6, 38.2, 26.5, 22.6; IR νmax 2945,
1677, 1557, 1529, 1401, 1358, 1222, 1159, 839, 705, 675 cm−1; MS
(ESI, +ve) m/z 241 [(M + Na)+, 100%], 219 [(M + H)+, 15]; HRMS
m/z (M + Na)+ calcd for C11H10N2NaO3 241.0589, found 241.0589.
6,7,8,9-Tetrahydro-5H-pyrido[4,3-b]indole (15). A magnetically
stirred mixture of compound 14 (50 mg, 0.23 mmol) and 10 wt %
Pd/C (20 mg) in degassed methanol (12 mL) was maintained under
an atmosphere of hydrogen at 22 °C for 16 h and then ﬁltered, and the
solids so retained were washed with methanol (25 mL). The combined
ﬁltrates were concentrated under reduced pressure, and the white solid
thus obtained was subjected to ﬂash column chromatography (silica,
1:4 v/v methanol/dichloromethane elution) to give, after concen-
tration of the appropriate fractions [Rf = 0.3(5) in 1:1 v/v methanol/
dichloromethane], compound 1523 (26 mg, 66%) as a white,
crystalline solid: mp = 223−224 °C (lit.23 mp = 269−271 °C); 1H
NMR (700 MHz, CD3OD) δ 8.58 (broad s, 1H), 8.05 (broad s, 1H),
7.28 (d, J = 5.3 Hz, 1H), 2.74 (m, 4H), 1.95−1.87 (complex m, 4H)
(signal due to N−H group proton not observed); 13C NMR (175
MHz, CD3OD) δ 141.6, 139.9, 139.1, 138.1, 126.2, 110.3, 107.5, 24.2,
24.1, 23.9, 21.6; IR νmax 2926, 2839, 2693, 1625, 1466, 1294, 1169,
1142, 989, 802, 684 cm−1; MS (ESI, +ve) m/z 173 [(M + H)+, 100%];
HRMS m/z (M + H)+ calcd for C11H13N2 173.1079, found 173.1078.
5H-Pyrido[4,3-b]indole (γ-Carboline, 3). A magnetically stirred
mixture of compound 15 (20 mg, 0.12 mmol) and 10 wt % Pd/C (20
mg) in diphenyl ether (15 mL) maintained under a nitrogen
atmosphere was heated at 210 °C for 0.66 h. The reaction mixture
was then cooled to room temperature and ﬁltered (through ﬁlter
paper), and the solids thus retained were washed with ethyl acetate (2
× 15 mL). The combined ﬁltrates were concentrated under reduced
pressure, and the residue thus obtained was subjected to ﬂash column
chromatography (silica, 40−60 petroleum ether elution → 1:3 v/v
methanol/dichloromethane gradient elution) to give, after concen-
tration of the appropriate fractions [Rf = 0.2(5) in 1:3 v/v methanol/
dichloromethane], compound 324 (15 mg, 77%) as a white, crystalline
solid: mp = 223−225 °C (lit.24 mp = 225−227 °C); 1H NMR [700
MHz, (CD3)2SO] δ 11.69 (s, 1H), 9.33 (s, 1H), 8.43 (s, 1H), 8.22 (d,
J = 7.8 Hz, 1H), 7.56 (m, 1H), 7.47 (m, 2H), 7.26 (t, J = 7.4 Hz, 1H);
13C NMR [175 MHz, (CD3)2SO] δ 144.5, 143.5, 142.7, 139.5, 126.5,
120.7, 120.6, 119.9, 119.4, 111.4, 106.4; 1H NMR (700 MHz,
CD3OD) δ 9.20 (s, 1H), 8.36 (s, 1H), 8.16 (d, J = 7.8 Hz, 1H), 7.53
(d, J = 8.1 Hz, 1H), 7.49−7.46 (m, 2H), 7.28 (t, J = 7.4 Hz, 1H)
(signal due to N−H group proton not observed); 13C NMR (175
MHz, CD3OD) δ 145.8, 144.4, 142.7, 141.5, 128.2, 122.4, 121.6(4),
121.6(0), 121.5, 112.4, 107.6; IR νmax 3062, 2956, 2806, 2679, 1607,
1582, 1467, 1239, 999, 744 cm−1; MS (ESI, +ve) m/z 169 [(M + H)+,
100%]; HRMS m/z (M + H)+ calcd for C11H9N2 169.0766, found
169.0766.
2-(3-Nitropyridin-2-yl)cyclohex-2-en-1-one (17). A magnetically
stirred mixture of 2-iodocyclohex-2-en-1-one (6) (1.09 g, 4.93 mmol),
copper powder (630 mg, 9.85 mmol), CuI (704 mg, 3.69 mmol), and
Pd(dppf)Cl2·CH2Cl2 (200 mg, 0.25 mmol) in degassed DMSO (50
mL) was heated at 50 °C under a nitrogen atmosphere for 0.75 h.
After this time, a solution of compound 16 (500 mg, 4.93 mmol) in
degassed DMSO (12 mL) was added to the reaction mixture over 1 h.
After a further 2 h, the reaction mixture was cooled, quenched with
water (10 mL), diluted with ethyl acetate (15 mL), and then ﬁltered
through a pad comprised of a mixture of diatomaceous earth and silica
gel. The solids thus retained were rinsed with ethyl acetate (2 × 15
mL), and the separated organic phase associated with the combined
ﬁltrates was washed with water (2 × 30 mL) and then brine (2 × 30
mL) before being dried (Na2SO4), ﬁltered, and concentrated under
reduced pressure to give a brown oil. Subjection of this material to
ﬂash column chromatography (silica, 1:3:12 v/v/v acetone/dichloro-
methane/40−60 petroleum ether elution) gave, after concentration of
the appropriate fractions [Rf = 0.1(5) in 1:3:6 v/v/v acetone/
dichloromethane/40−60 petroleum ether], compound 17 (403 mg,
75%) as a light-brown solid: mp = 104−106 °C; 1H NMR (400 MHz,
CDCl3) δ 8.79 (dd, J = 4.7 and 1.3 Hz, 1H), 8.29 (dd, J = 8.2 and 1.3
Hz, 1H), 7.49−7.43 (complex m, 2H), 2.65 (m, 2H), 2.58 (m, 2H),
2.20−2.13 (complex m, 2H); 13C NMR (100 MHz, CDCl3) δ 196.2,
152.9, 151.0, 149.4, 146.1, 139.2, 132.2, 123.4, 38.3, 26.6, 22.5; IR νmax
2947, 1677, 1593, 1561, 1526, 1451, 1357, 765 cm−1; MS (ESI, +ve)
m/z 241 [(M + Na)+, 100%], 219 [(M + H)+, 15]; HRMS m/z (M +
Na)+ calcd for C11H10N2NaO3 241.0589, found 241.0589.
6,7,8,9-Tetrahydro-5H-pyrido[3,2-b]indole (18). A magnetically
stirred mixture of compound 17 (213 mg, 0.98 mmol) and 10 wt %
Pd/C (86 mg) in degassed methanol (49 mL) was maintained under
an atmosphere of hydrogen for 16 h at 22 °C and then ﬁltered, and the
solids so retained were washed with methanol (100 mL). The
combined ﬁltrates were concentrated under reduced pressure, and the
white solid thus obtained was subjected to ﬂash column chromatog-
raphy (silica, 1:1 v/v ethyl acetate/40−60 petroleum ether elution) to
give, after concentration of the appropriate fractions (Rf = 0.2 in 1:1 v/
v ethyl acetate/40−60 petroleum ether), compound 1825 (109 mg,
65%) as a white, crystalline solid: mp = 183−185 °C (lit.25 mp = 200−
202 °C); 1H NMR (400 MHz, CDCl3) δ 8.86 (broad s, 1H), 8.38 (d, J
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= 4.3 Hz, 1H), 7.52 (d, J = 7.9 Hz, 1H), 7.00 (m, 1H), 2.84 (m, 2H),
2.76 (m, 2H), 1.95−1.84 (complex m, 4H); 13C NMR (100 MHz,
CDCl3) δ 145.6, 141.9, 139.2, 129.1, 117.4, 115.8, 110.8, 23.8, 23.2,
23.1, 20.1; IR νmax 3136, 3083, 3053, 2929, 2847, 1483, 1414, 1362,
1286, 1144, 904, 767, 729 cm−1; MS (ESI, +ve) m/z 173 [(M + H)+,
100%]; HRMS m/z (M + H)+ calcd for C11H13N2 173.1079, found
173.1080.
5H-Pyrido[3,2-b]indole (δ-Carboline, 4). A magnetically stirred
mixture of compound 18 (20 mg, 0.12 mmol) and 10 wt % Pd/C (20
mg) in diphenyl ether (15 mL) maintained under a nitrogen
atmosphere was heated at 210 °C for 0.66 h. The reaction mixture
was then cooled to room temperature and ﬁltered (through ﬁlter
paper), and the solids thus retained were washed with ethyl acetate (2
× 15 mL). The combined ﬁltrates were concentrated under reduced
pressure, and the residue thus obtained was subjected to ﬂash column
chromatography (silica, 0:1→ 1:4 v/v ethyl acetate/40−60 petroleum
ether gradient elution) to give, after concentration of the appropriate
fractions [Rf = 0.2(5) in 1:1 v/v ethyl acetate/40−60 petroleum
ether], compound 426 (18 mg, 92%) as a white, crystalline solid: mp =
211−212 °C (lit.26 mp = 206−207 °C); 1H NMR (400 MHz,
CD3OD) δ 8.39 (dd, J = 4.8 and 1.4 Hz, 1H), 8.28 (d, J = 7.9 Hz, 1H),
7.88 (d, J = 8.2 Hz, 1H), 7.52 (m, 2H), 7.40 (m, 1H), 7.26 (m, 1H)
(signal due to N−H group proton not observed); 13C NMR (100
MHz, CD3OD) δ 142.4, 142.3, 141.5, 135.1, 129.0, 122.4, 121.4, 121.3,
120.8, 119.9, 112.6; IR νmax 3057, 2979, 2919, 2848, 2760, 1629, 1460,
1396, 1320, 1223, 741, 724 cm−1; MS (ESI, +ve) m/z 169 [(M + H)+,
100%]; HRMS m/z (M + H)+ calcd for C11H9N2 169.0766, found
169.0766.
2-Methylpyridin-4-ol Nitrate (20). Commercially available 2-
methylpyridin-4-amine (8.00 g, 73.98 mmol) was dissolved in a
mixture of concentrated HNO3 (44.1 mL) and H2O (59.4 mL), and
the resulting solution was cooled, with vigorous magnetic stirring, to 0
°C. A chilled solution of NaNO2 (7.40 g, 107.25 mmol) in water (21.7
mL) was then added dropwise over 0.5 h, and the mixture thus formed
stirred at 0 °C for 4 h before being allowed to warm to 22 °C and then
stirred at this temperature for another 10 h and was recooled to 0 °C.
The resulting solid was removed by ﬁltration, the ﬁltrate was
concentrated to about one-third of its original volume and then
cooled to 0 °C, and a second crop of solid was removed by ﬁltration.
The combined solids were then air-dried to give the nitric acid salt27 of
compound 20 (10.49 g, 82%) as a white, crystalline solid: mp = 162−
164 °C (lit.27 mp = 164−165 °C); 1H NMR (400 MHz, CD3OD) δ
8.34 (d, J = 6.5 Hz, 1H), 7.11−7.09 (complex m, 2H), 2.62 (s, 3H)
(signals due to O−H and N−H group protons not observed); 13C
NMR (100 MHz, CD3OD) δ 173.4, 156.0, 143.2, 114.7, 113.0, 19.3;
IR νmax 3098, 2919, 2617, 1627, 1501, 1305, 1216, 830 cm
−1; MS (ESI,
+ve) m/z 110 [(M + H)+, 100%]; HRMS m/z (M + H)+ calcd for
C6H8NO 110.0606, found 110.0608.
2-Methyl-4-nitropyridin-3-ol (21) and 2-Methyl-3-nitropyridin-4-
ol (22). A magnetically stirred solution of salt 20 (3.00 g, 17.43 mmol)
in concentrated H2SO4 (6.9 mL) was cooled to 0 °C and then treated,
dropwise, with fuming HNO3 (6.9 mL). The ensuing mixture was
stirred at 0 °C for 0.17 h, heated at 130 °C for 20 h, and then cooled
to 0 °C and carefully neutralized with NaOH (25 mL of a 10 M
aqueous solution). FC-grade silica gel (20 g) was added to the ensuing
mixture, and this was then concentrated under reduced pressure. The
free-ﬂowing solid thus obtained was subjected to ﬂash column
chromatography (silica, 1:19 v/v methanol/dichloromethane elution)
to give, after concentration of the appropriate fractions (Rf = 0.6 in 1:1
v/v methanol/dichloromethane), a 1:3 mixture of 2-methyl-5-
nitropyridin-4-ol (21) and 2-methyl-3-nitropyridin-4-ol (22) (1.88 g,
70% combined yield) as a white crystalline solid: mp = 148−150 °C;
1H NMR [400 MHz, (CD3)2SO] δ (major product) 12.17 (broad s,
1H), 7.72 (d, J = 7.5 Hz, 1H), 6.33 (d, J = 7.5 Hz, 1H), 2.29 (s, 3H);
13C NMR [100 MHz, (CD3)2SO] δ (for mixture) 168.2, 151.2, 148.1,
143.5, 142.2, 139.4, 137.8, 137.3, 120.7, 118.0, 18.2, 15.3; IR νmax 3037,
2796, 1612, 1557, 1502, 1356, 1222, 836, 768 cm−1; MS (ESI, +ve) m/
z 331 (42%), 177 [(M + Na)+, 100], 155 [(M + H)+, 10]; HRMS
(ESI) m/z (M + Na)+ calcd for C6H6N2NaO3 177.0276, found
177.0278.
4-Bromo-2-methyl-3-nitropyridine (24). A magnetically stirred 1:3
mixture of 2-methyl-5-nitropyridin-4-ol (21) and 2-methyl-3-nitro-
pyridin-4-ol (22) (1.12 g, 7.27 mmol), obtained as described
immediately above, in toluene (8.0 mL) and maintained under a
nitrogen atmosphere was treated with POBr3 (2.19 g, 7.63 mmol). The
ensuing mixture was heated under reﬂux for 10 h and then cooled to 0
°C before being quenched with NaOH (30 mL of a 1 M aqueous
solution). The ensuing mixture was extracted with ethyl acetate (1 ×
150 mL) and washed with H2O (2 × 150 mL). The separated organic
phase was then dried (Na2SO4), ﬁltered, and concentrated under
reduced pressure. The solid so obtained was subjected to ﬂash column
chromatography (silica, 1:3:20 v/v/v acetone/dichloromethane/40−
60 petroleum ether elution) to give, after concentration of the
appropriate fractions (Rf = 0.4 in 1:3:6 v/v/v acetone/dichloro-
methane/40−60 petroleum ether), a 1:3 mixture of what is presumed
to be 4-bromo-2-methyl-5-nitropyridine (23) and 4-bromo-2-methyl-
3-nitropyridine (24) (1.46 g, 92% combined) as a white solid. A ca.
800 mg portion of this material was subjected to semipreparative
HPLC (silica, normal phase, 17:83 v/v ethyl acetate/n-hexane elution,
600 mL/h) to aﬀord, after concentration of the relevant fractions (Rt =
0.45 h), a pure sample of 4-bromo-2-methyl-3-nitropyridine (24) (ca.
350 mg) as a white, crystalline solid: mp = 78−79 °C; 1H NMR (400
MHz, CDCl3) δ 8.40 (d, J = 5.3 Hz, 1H), 7.50 (d, J = 5.3 Hz, 1H),
2.60 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 151.8, 150.5, 148.5,
126.3, 123.7, 20.9; IR νmax 3072, 1575, 1534, 1365, 1266, 846, 837, 714
cm−1; MS (EI, 70 eV) m/z 218 and 216 (M+•, both 90%), 201 and
199 (both 70), 172 and 170 (both 95), 93 and 91 (both 83), 62
(100%); HRMS m/z M+• calcd for C6H5
79BrN2O2 215.9534, found.
215.9533.
2-(2-Methyl-3-nitropyridin-4-yl)cyclohex-2-en-1-one (25). A mag-
netically stirred mixture of 2-iodocyclohex-2-en-1-one (6) (205 mg,
0.92 mmol), copper powder (117 mg, 1.84 mmol), CuI (132 mg, 0.69
mmol), and Pd(dppf)Cl2·CH2Cl2 (38 mg, 0.05 mmol) in degassed
DMSO (9 mL) was heated at 50 °C under a nitrogen atmosphere for
0.75 h. After this time, a solution of compound 24 (100 mg, 0.46
mmol) in degassed DMSO (3 mL) was added to the reaction mixture
over 0.66 h. After a further 6 h the reaction mixture was cooled,
quenched with water (3 mL), and then diluted with ethyl acetate (5
mL). The ensuing mixture was ﬁltered through a pad comprised of a
mixture of diatomaceous earth and silica gel, and the solids so retained
were rinsed with ethyl acetate (2 × 5 mL). The separated organic
phase associated with the combined ﬁltrates was washed with water (2
× 10 mL) and then brine (2 × 10 mL) before being dried (Na2SO4),
ﬁltered, and concentrated under reduced pressure to give a brown oil.
Subjection of this material to ﬂash column chromatography (silica,
3:9:40 v/v/v acetone/dichloromethane/40−60 petroleum ether
elution) gave, after concentration of the appropriate fractions [Rf =
0.1(5) in 1:3:6 v/v/v acetone/dichloromethane/40−60 petroleum
ether], compound 25 (90 mg, 84%) as a light-brown, crystalline solid:
mp = 80−81 °C; 1H NMR (400 MHz, CDCl3) δ 8.59 (d, J = 5.0 Hz,
1H), 7.09−7.05 (complex m, 2H), 2.66 (s, 3H), 2.58−2.54 (complex
m, 4H), 2.12 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 195.6, 151.4,
150.8, 150.1, 146.6, 139.0, 136.3, 123.4, 38.2, 26.5, 22.5, 22.0; IR νmax
2939, 1681, 1594, 1528, 1359, 1229, 860 cm−1; MS (ESI, +ve) m/z
255 [(M + Na)+, 100%], 233 [(M + H)+, 10]; HRMS m/z (M + Na)+
calcd for C12H12N2NaO3 255.0746, found 255.0734.
1-Methyl-6,7,8,9-tetrahydro-5H-pyrido[3,4-b]indole (26). A mag-
netically stirred mixture of compound 25 (103 mg, 0.44 mmol) and 10
wt % Pd/C (42 mg) in degassed methanol (22 mL) was maintained
under an atmosphere of hydrogen at 22 °C for 16 h and then ﬁltered,
and the solids thus retained were washed with methanol (50 mL). The
combined ﬁltrates were concentrated under reduced pressure, and the
white solid thus obtained was subjected to ﬂash column chromatog-
raphy (silica, 1:4 v/v methanol/dichloromethane elution) to give, after
concentration of the appropriate fractions (Rf = 0.2 in 1:1 v/v
methanol/dichloromethane), compound 2628 (69 mg, 83%) as a
white, crystalline solid: mp = 187−189 °C (lit.28 mp = 184−188 °C);
1H NMR (400 MHz, CD3OD) δ 7.84 (d, J = 5.4 Hz, 1H), 7.19 (d, J =
5.4 Hz, 1H), 2.78 (broad s, 2H), 2.63 (broad s, 5H), 1.91−1.84
(complex m, 4H) (signal due to N−H group proton not observed);
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13C NMR (100 MHz, CD3OD) δ 141.6, 141.2, 136.7, 133.7, 132.9,
111.9, 110.6, 24.3, 24.2, 24.1, 21.7, 19.1; IR νmax 3045, 2930, 2846,
1563, 1498, 1308, 1226, 809 cm−1; MS (ESI, +ve) m/z 187 [(M +
H)+, 100%]; HRMS m/z (M + H)+ calcd for C12H15N2 187.1235,
found 187.1232.
1-Methyl-9H-pyrido[3,4-b]indole (Harman, 5). A magnetically
stirred mixture of compound 26 (36 mg, 0.19 mmol) and 10 wt %
Pd/C (36 mg) in diphenyl ether (15 mL) maintained under a nitrogen
atmosphere was heated at 210 °C for 0.66 h. The reaction mixture was
then cooled to room temperature and ﬁltered (through ﬁlter paper),
and the solids so retained were washed with ethyl acetate (2 × 7 mL).
The combined ﬁltrates were concentrated under reduced pressure, and
the residue thus obtained was subjected to ﬂash column chromatog-
raphy (silica, 40−60 petroleum ether elution →1:9 v/v methanol/
dichloromethane elution) to give, after concentration of the
appropriate fractions (Rf = 0.5 in 1:3 v/v methanol/dichloromethane),
compound 529 (32 mg, 91%) as a white, crystalline solid: mp = 233−
235 °C (lit.29 mp = 235−238 °C); 1H NMR (400 MHz, CDCl3) δ
8.91 (broad s, 1H), 8.38 (d, J = 5.4 Hz, 1H), 8.12 (d, J = 7.9 Hz, 1H),
7.84 (d, J = 5.4 Hz, 1H), 7.56−7.51 (complex m, 2H), 7.29 (m, 1H),
2.84 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 141.9, 140.3, 138.7,
134.8, 128.5, 128.4, 122.2, 122.0, 120.2, 113.1, 111.7, 20.5; IR νmax
3135, 3068, 2925, 1626, 1568, 1504, 1450, 1323, 1251, 1237, 742
cm−1; MS (ESI, +ve) m/z 183 [(M + H)+, 100%]; HRMS (ESI) m/z
(M + H)+ calcd for C12H11N2 183.0922, found 183.0922.
X-ray Crystallographic Studies. Crystallographic Data. Com-
pound 1. C11H8N2, M = 168.20, T = 150 K, monoclinic, space group
P21/n, Z = 4, a = 11.1814(2) Å, b = 5.53776(8) Å, c = 13.4546(2) Å, β
= 96.2939(15)°, V = 828.09(2) Å3, Dx = 1.349 g cm−3, 1673 unique
reﬂections (2θmax = 147.6°), R = 0.035 [for 1520 reﬂections with I >
2.0σ(I)], Rw = 0.089 (all data), S = 1.00.
Compound 2. C11H8N2, M = 168.20, T = 150 K, orthorhombic,
space group P212121, Z = 4, a = 5.8440(1) Å, b = 9.8140(1) Å, c =
14.4195(1) Å, V = 827.00(2) Å3, Dx = 1.351 g cm
−3, 1004 unique
reﬂections (2θmax = 147.8°), R = 0.027 [for 998 reﬂections with I >
2.0σ(I)], Rw = 0.073 (all data), S = 1.00.
Compound 3. C11H8N2, M = 168.20, T = 150 K, orthorhombic,
space group Pna21, Z = 4, a = 17.1576(6) Å, b = 12.2955(6) Å, c =
3.8213(2) Å, V = 806.15(6) Å3, Dx = 1.386 g cm
−3, 944 unique
reﬂections (2θmax = 147.8°), R = 0.032 [for 906 reﬂections with I >
2.0σ(I)], Rw = 0.062 (all data), S = 1.00.
Compound 4. C11H8N2, M = 168.20, T = 150 K, monoclinic, space
group Ia, Z = 4, a = 12.1155(7) Å, b = 3.9036(2) Å, c = 18.1199(13)
Å, β = 107.250(7)°, V = 818.42(9) Å3, Dx = 1.365 g cm−3, 820 unique
reﬂections (2θmax = 146.6°), R = 0.042 [for 807 reﬂections with I >
2.0σ(I)], Rw = 0.107 (all data), S = 1.05.
Compound 5. C12H10N2, M = 182.23, T = 150 K, orthorhombic,
space group P212121, Z = 8, a = 9.5865(2) Å, b = 13.2423(4) Å, c =
15.1680(4) Å, V = 1925.54(9) Å3, Dx = 1.257 g cm
−3, 1994 unique
reﬂections (2θmax = 52.0°), R = 0.032 [for 1805 reﬂections with I >
2.0σ(I)], Rw = 0.073 (all data), S = 1.00.
Structure Determination. Images for compound 5 were collected
on a diﬀractometer (Mo Kα, graphite monochromator, λ = 0.71073 Å)
ﬁtted with an area detector, and the data were extracted using CrysAlis
PRO.34 Images for compounds 1, 2, 3, and 4 were measured on a
diﬀractometer (Cu Kα, mirror monochromator, λ = 1.54184 Å) ﬁtted
with an area detector, and the data were extracted using the CrysAlis
PRO.34 The structure solutions for all 5 compounds were solved by
direct methods (SIR92)35 and then reﬁned using the CRYSTALS
program package.36 Atomic coordinates, bond lengths and angles, and
displacement parameters have been deposited at the Cambridge
Crystallographic Data Centre (CCDC nos. 1530002, 1530003,
1530004, 1530005, 1530006). These data can be obtained free-of-
charge via www.ccdc.cam.ac.uk/data_request/cif, by e-mailing data_
request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallo-
graphic Data Centre (12 Union Road, Cambridge CB2 1EZ, UK; fax:
+ 44 1223 336033).
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Figure S1: Structure of compound 1 (CCDC 1530002) with labeling of selected atoms. Anisotropic displacement ellipsoids show 30% 
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Figure S2: Structure of compound 2 (CCDC 11530003) with labeling of selected atoms. Anisotropic displacement ellipsoids show 30% 
probability levels. Hydrogen atoms are drawn as circles with small radii. 
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Figure S3: Structure of compound 3 (CCDC 1530004) with labeling of selected atoms. Anisotropic displacement ellipsoids show 30% 
probability levels. Hydrogen atoms are drawn as circles with small radii. 
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Figure S4: Structure of compound 4 (CCDC 1530005) with labeling of selected atoms. Anisotropic displacement ellipsoids show 30% 
probability levels. Hydrogen atoms are drawn as circles with small radii.!!
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Figure S5: Structure of compound 5 (CCDC 1530006) with labeling of selected atoms. Anisotropic displacement ellipsoids show 30% 
probability levels. Hydrogen atoms are drawn as circles with small radii.!!
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Appendix A 
A Pd[0]-catalysed Ullmann Cross-coupling Route to Carbazoles 
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Carbon-carbon bond-forming reactions, especially cross-coupling variants, are a 
central aspect of contemporary synthetic chemistry. The Ullmann reaction is a 
classic C–C bond forming process. The original form of this reaction was 
reported in 1901[1] and involves homo-coupling of two equivalents of an aryl 
halide in the presence of copper powder at high temperature to give 
corresponding and symmetrical biaryl. The Pd[0]-catalysed Ullmann cross-
coupling reaction was first reported in 1993 by Shimizu and co-workers.[2] They 
used a range of Pd catalysts in combination with metallic copper and noted an 
attendant capacity to selectively form cross-coupling products under mild 
conditions. 
 
Our group has reported[3] a Pd[0]-catalysed Ullmann cross-coupling approach to 
indoles that employs readily available starting materials and reagents (Figure 1). 
Significantly, it avoids the need to use organostannanes and addresses the 
regiochemical issues associated with the traditional Fischer indole synthesis. 
This presentation will detail extensions of such processes to the preparation of 
carbazoles including a range of natural products containing this ring system. 
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The Pd[0]-catalysed Ullmann Cross-coupling Route to Carbazoles
Emma Gin and Martin G. Banwell
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Introduction
The Ullmann reaction is a classic C–C bond forming process. The original form of it was reported in 1901[1] and involves the homo-coupling of two
equivalents of an aryl halide in the presence of copper powder at high temperature to give the corresponding, symmetrical biaryl. The Pd[0]-catalysed
variant of the Ullmann cross-coupling reaction was first reported in 1993 by Shimizu and co-workers[2] who demonstrated the utility of this process for the
selective formation of cross-coupled products under relatively mild conditions. This presentation will detail the application of the title process to the
synthesis of carbazoles. Carbazole alkaloids are of great interest due to their diverse biological activities.[3] Indeed, certain carbazole–containing natural
products show antitumor, antibacterial and/or antifungal properties as well as, in some instances, activity against malaria.
The Pd[0]-catalysed Ullmann Cross-coupling Route to Carbazoles
A three-step sequence[4]
Step 1: The Pd[0]-catalysed Ullmann Cross-coupling Reaction[4]
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